N-tert-Butanesulfinyl imines in the asymmetric synthesis of nitrogen-containing heterocycles

  1. 1 ORCID Logo ,
  2. 2 ,
  3. 3,4,5 ,
  4. 3,4,5 ORCID Logo and
  5. 1 ORCID Logo
1Department of Chemistry, Pontifical Catholic University of Rio de Janeiro Puc-Rio, CEP 22435-900, Brazil
2Laboratory of Bioorganic Chemistry, Institute of Research of Natural Products, Health Science Center, Federal University of Rio de Janeiro UFRJ, CEP 21941-590, Brazil
3Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad de Alicante, Apdo.99, 03080 Alicante, Spain
  1. Corresponding author email
Associate Editor: B. Nay
Beilstein J. Org. Chem. 2021, 17, 1096–1140. https://doi.org/10.3762/bjoc.17.86
Received 26 Jan 2021, Accepted 22 Apr 2021, Published 12 May 2021
cc by logo


The synthesis of nitrogen-containing heterocycles, including natural alkaloids and other compounds presenting different types of biological activities have proved to be successful employing chiral sulfinyl imines derived from tert-butanesulfinamide. These imines are versatile chiral auxiliaries and have been extensively used as eletrophiles in a wide range of reactions. The electron-withdrawing sulfinyl group facilitates the nucleophilic addition of organometallic compounds to the iminic carbon with high diastereoisomeric excess and the free amines obtained after an easy removal of the tert-butanesulfinyl group can be transformed into enantioenriched nitrogen-containing heterocycles. The goal of this review is to the highlight enantioselective syntheses of heterocycles involving the use of chiral N-tert-butanesulfinyl imines as reaction intermediates, including the synthesis of several natural products. The synthesis of nitrogen-containing heterocycles in which the nitrogen atom is not provided by the chiral imine will not be considered in this review. The sections are organized according to the size of the heterocycles. The present work will comprehensively cover the most pertinent contributions to this research area from 2012 to 2020. We regret in advance that some contributions are excluded in order to maintain a concise format.


Chiral imines derived from tert-butanesulfinamide have been extensively used as electrophiles in a wide range of reactions. The presence of the chiral electron-withdrawing sulfinyl group facilitates the nucleophilic addition of organometallic compounds to the iminic carbon [1-3]. The ready availability of both enantiomers of tert-butanesulfinamide in large-scale processes, the easy deprotection of the amine under mild acidic conditions, and a practical procedure for recycling the chiral auxiliary [4,5] have contributed to the widespread use of these imines as precursors of chiral compounds with a nitrogen atom bonded to a stereogenic center. The amine derivatives, resulting after removal of the tert-butanesulfinyl group, can be transformed into enantioenriched nitrogen-containing heterocycles [6,7] including natural alkaloids [8-11] and other compounds that show different types of biological activities [12,13]. The way to achieve these transformations is by intramolecular cyclizations, involving the free primary amine, and appropriate reactive positions (those positions bearing a leaving group) in the electrophile or in the carbonyl component of the starting imine (Scheme 1).


Scheme 1: General strategy for the enantioselective synthesis of N-containing heterocycles from N-tert-butanesulfinyl imines.

Synthesis of tert-butane N-sulfinyl imines

The first method developed for the synthesis of enantiomerically pure N-tert-butanesulfonamide 1 was reported by Ellman and co-workers [14,15]. In 1999, they described the synthesis of imines from the condensation reaction of aldehydes or ketones with tert-butanesulfinamides. In this work, the condensation with aldehydes was carried using Ti(OEt)4 in tetrahydrofuran (THF), or CuSO4 in dichloromethane at room temperature. The combination of MgSO4 in the presence of a catalytic amount of pyridinium p-toluenesulfonate (PPTS) also worked well to perform these condensations [1,16]. For the formation of aldimines, other methodologies are described in the literature using condensation reagents such as Yb(OTf)3 [17], Cs2CO3 [18] and KHSO4 [19]. However, for the synthesis of ketimines, Ti(OEt)4 was the only effective reagent when performing the reaction at 60 °C in THF [16]. Ketimines were also synthesized with Ti(OEt)4, under microwave irradiation in a solvent-free system [20]. In hindered ketones, Ti(OiPr)4 or Ti(OEt)4 using vacuum or under a nitrogen flow were effective to tert-butanesulfinyl ketimine condensation (Scheme 2) [21].


Scheme 2: Methodologies for condensation of aldehydes and ketones with tert-butanesulfinamides (1).

Mechanism of addition of nucleophiles to N-sulfinyl imines

The p-toluenesulfinamide 5 was first described by Davis and co-workers in a racemic form [22], and subsequently, the compound was prepared and isolated as a single enantiomer [23,24], becoming an important tool in the asymmetric synthesis of aziridines [25,26], α-amino acids [27,28], β-amino acids [23,29] and branched α-amines [30,31]. The Darzens-type asymmetric synthesis of N-(p-toluenesulfinyl)aziridine 2-carboxylate esters (7 and 8) was described through the addition of lithium α-bromoenolates to enantiopure p-toluenesulfinamide 5. cis-aziridine 7a was formed as the major diastereoisomer in 89% yield and the trans-isomer in 8% yield in a one-step procedure using lithium enolates of methyl bromoacetate 6a and sulfinyl imine 5. Lithium enolates of methyl α-bromopropionate gave trans-aziridine in 50% yield under the same conditions. The transition state is proposed with a six-membered chair-like transition containing a four-membered metallocycle. In cis-aziridine the enolate of methyl α-bromoacetate has E-geometry and the trans-aziridine 8a has Z-geometry [32,33]. In the transition state, the metal cation of the enolate is being coordinated with both nitrogen and oxygen atoms of the sulfinimine [25,26] (Scheme 3).


Scheme 3: Transition models for cis-aziridines and trans-aziridines.

In 1999, Ellman and co-workers described the reduction of sulfinyl imines using sodium borohydride (NaBH4) [34] or o ʟ-selectride [35]. Davis–Ellman transition state models were proposed to rationalize organometallic additions to N-sulfinyl imines. The mechanism for obtaining these two stereoisomers was elucidated in the work published by Andersen and co- workers [36]. The origin of the reversal of the diastereofacial selectivity on the change of reducing agents is based on the operating transition states [37,38]. A cyclic transition state is proposed in the reaction with sodium borohydride. In this transition state, the oxygen of the sulfinyl group interacts with the boron atom, facilitating the release of the hydride, directing the attack to the Si-face of the imine with (RS,E) configuration. When the reduction is performed with ʟ-selectride, with the poorly coordinating metal hydride, an open transition state operates due to the bulkiness of the isobutyl groups bonded to the boron atom. In this case, the attack of the hydride takes place to the less hindered Re-face of the imine (Scheme 4) [1,36].


Scheme 4: Mechanism for the reduction of N-tert-butanesulfinyl imines.

The nucleophilic addition reactions to N-tert-butanesulfinyl imines were also described by Ellman and co-workers who reported the addition of allylmagnesium bromide to ketimines. The employment of Grignard reagents showed greater diastereoselectivity than reactions using organolithium and organocerium compounds. In some examples, the use of organolithium is feasible through the use of aluminum-derived additives [15]. In this study, the influence of solvents on diastereoselectivity was also observed. They found that the reactions performed in noncoordinating solvents, such as toluene and dichloromethane, took place with high diastereoselectivity. However, solvents such as ether and THF had a negative impact on stereoselectivity [15]. On the other hand, recent studies developed by Sirvent and Foubelo demonstrated the influence of the solvents in both the yield and diastereoselectivity in these reactions. They found that working in THF led to higher yields and poorer diastereoselectivities than when the reactions were performed in less coordinating solvents, such as diethyl ether and toluene [39].

Based on a broader analysis related to the effects of the solvent, metal and additives in 1,2-addition reactions to N-tert-butanesulfinyl imines of organometallic compounds, different transition models have been proposed to explain the stereochemical outcomes. The cyclic model justified by the Zimmermann–Traxler transition state [40-42] is the typical mechanism operating in reactions involving Grignard reagents in noncoordinating solvents, such as toluene and dichloromethane, while an acyclic model [43] is common in organolithium compounds in solvents such as THF. In the cyclic model, the bulky tert-butyl group occupies an equatorial position due to steric hindrance [1,14,44,45] (Scheme 5).


Scheme 5: Transition models for the addition of organomagnesium and organolithium compounds to N-tert-butanesulfinyl imines.

Other contributions to the nucleophilic addition reactions to N-tert-butanesulfinyl imines were made by Yus and co-workers employing organozincates [46-49] and indium [50].

After this brief about the synthesis of enantiomerically pure N-tert-butanesulfonamide and applications in some nucleophilic additions, the next sections will describe the synthesis of several alkaloids according to the size of the heterocycles. We regret in advance that some contributions are excluded in order to maintain a concise format.


Asymmetric synthesis of aziridines

Saturated nitrogen-containing three-membered heterocycles have attracted increasing interest in recent years because compounds with this structural motif display quite diverse pharmacological activities. Chiral aziridines [51] also play an important role in asymmetric synthesis because they can act both as ligands [52-55] and as chiral auxiliaries [56]. The most widely used synthetic methods to form the aziridine ring [57-61] include intramolecular cyclizations in amines bearing potential leaving groups. Stereoselective syntheses of aziridines have been successfully carried out by combining a nucleophilic addition to N-tert-butanesulfinyl α-chloroimines, and an intramolecular cyclization, the chlorine atom being finally displaced. Chiral N-tert-butanesulfinyl aldimines and ketimines have also been used successfully to form aziridines through aza-Darzens and Corey–Chaykovsky reactions [62,63].

The first asymmetric synthesis of 2,2-dibromoaziridines 15 was achieved by performing the nucleophilic addition of the anion resulting from the deprotonation of bromoform with sodium hexamethyldisilazide (NaHMDS) to chiral N-tert-butanesulfinyl aldimines (RS)-14, at low temperature, and using DMF as solvent. After addition, a subsequent intramolecular cyclization involving the resulting amide and the vicinal carbon with bromine atoms took place. By contrary, when the reaction was carried out in THF, the elimination process was suppressed, leading exclusively to enantiomerically pure α-tribromomethylamines 16. The structure and configuration of aziridines 15 were determined unambiguously by single crystal X-ray analysis [64]. In order to explain the experimental results, a nonchelation controlled transition state was proposed. Based on computational studies, it is known that a kind of s-cis arrangement of the sulfinyl group is the most stable conformation of the imine, due to the contribution of the hydrogen bonding of the oxygen and the iminic hydrogen. In this scenario, the tribromomethyl anion attacked the less hindered Re face of the imine with (RS) configuration (Scheme 6).


Scheme 6: Synthesis of 2,2-dibromoaziridines 15 from aldimines 14 and bromoform, and proposed non-chelation-controlled transition state model.

The applicability of sulfinyl imines was also shown by Garcia Ruano and co-workers. (SS)-tert-Butanesulfinyl imine 17b provided better diastereoselectivity to obtain aziridines 18b than (SS)-tert-butanesulfinyl imine 17a to obtain aziridines 18a (Scheme 7) [65].


Scheme 7: Diastereoselective synthesis of aziridines from tert-butanesulfinyl imines.

Allylation of N-tert-butanesulfinyl imines 14 with allylic bromides in the presence of zinc or indium metals is a well-known reaction [66,67]. It is possible to control and predict the stereochemistry of the addition to get the corresponding homoallylamine derivative with a high level of stereocontrol. The reaction of chiral imine 14 with an excess of 1,3-dibromopropene (23) in THF at 50 °C for 2 h, and a 1000 rpm rotation speed, led to trans-vinylaziridines 22, in moderate yields and high diastereoselectivities. Those were the reaction conditions that Sun and co-workers found to be optimal for the formation of the vinylaziridines [68]. However, when the allylation was performed in the presence of indium metal, in a saturated aqueous solution of sodium bromide, a mixture of the bromoallylation and allylation products 25 and 26, respectively, were obtained [69]. The addition of the allyl unit to the imines proceeded with total facial diastereoselectivity, producing also preferably diastereoisomers with anti relative configuration. According to the mechanism depicted on Scheme 8, the allyl unit reacted at γ-position, taking place the addition to the Si face of the imines with RS configuration. The bromoallylated product 24 was obtained as a mixture of anti/syn diastereoisomers. Treatment of compounds 24 with potassium hexamethyldisilazide provided vinylaziridines 22 through an intramolecular cyclization step. This intramolecular nucleophilic substitution is a stereospecific process. In the case of aromatic compounds 24, trans-vinylaziridines were the only reaction products, meanwhile for aliphatic derivatives 24 (R = alkyl), trans- and cis-aziridines 22 were isolated in practically the same ratio as the anti/syn ratio of their precursors 24. This shows that the cyclization reaction is stereospecific (Scheme 8). Comparing both methodologies, the indium-mediated bromoallylation seemed to be superior, since aliphatic aldimines 14 were compatible with this approach.


Scheme 8: Synthesis of vinylaziridines 22 from aldimines 14 and 1,3-dibromopropene 23, and proposed chelation controlled transition state model.

The group of Stockman reported the synthesis of 2,2′,3-substituted aziridines 27 from N-tert-butanesulfinyl imines 14 and α-bromoesters 26 by applying an aza-Darzens methodology [70]. The reactions were performed in THF at −78 °C, using lithium hexamethyldisilazide as base. Aziridines with relative trans-configuration were obtained in good yields and excellent stereoselectivities with methyl α-bromo-α-phenylacetate (26, R2 = Ph). Lower yields, and poorer diastereoselectivities were observed with less bulky methyl 2-bromo-2-butenoate (R2 = CH3CH=), leading to an almost complete loss of cis/trans selectivity by the reaction with aliphatic aldimines 14. The absolute configuration of the reaction products was unambiguously determined after X-ray crystallographic analysis of some of the reaction products. In order to rationalize the observed stereochemical outcome, a six-membered cyclic transition state has been proposed. The addition to imine 14 with SS configuration takes place on the less hindered Re face, on the other hand, the cis/trans selectivity observed being a consequence of the E stereochemistry of both the imine 14 and the enolate derived from bromoester 26 (Scheme 9).


Scheme 9: Synthesis of vinylaziridines 27 from aldimines 14 and α-bromoesters 26, and proposed transition state leading to the major diastereoisomer.

A two-step protocol carried out in a single synthetic operation was developed by Chen and Zhang to synthesize 3-substituted 2-chloroaziridines with relative cis configuration [71]. The reaction of chiral imines 14 in dichloromethane in the presence of 2 equivalents of phenyllithium at −78 °C to room temperature produced the expected 2-chloroaziridines with excellent yields and diastereoselectivities. Under the previously commented optimized reaction conditions, dichloromethyllithium is first generated, taking place a diastereoselective nucleophilic dichloromethylation of the imine. The addition took place almost exclusively to the Re face of the imine (RS)-14, which is the less sterically hindered in the most stable s-cis conformation (see Scheme 2). The second intramolecular N-alkylation step produced the 2-chloroaziridines 28 with relative cis configuration. The absolute proposed configurations were confirmed by X-ray crystallographic analysis (Scheme 10).


Scheme 10: Synthesis of 2-chloroaziridines 28 from aldimines 14 and dichloromethane, and proposed transition state model for the nucleophilic addition and for the elimination step.

An interesting asymmetric vinylogous aza-Darzens reaction was employed to access cis-vinylaziridines 30 and 31. The group of Njardarson found that the reaction of different aromatic and aliphatic chiral imines (SS)-14 with the dienolate resulting from the deprotonation of bromomethyl butenolide 29 in THF at −78 °C led to a mixture of diastereomeric cis-vinylaziridines 30 and 31 with good yields in most cases. Lithium hexamethyldisilazide was the base of choice to perform the deprotonation, and it must be added very slowly to the reaction mixture in order to suppress self-dimerization of the butenolide [72]. The structures as well as the absolute and relative stereochemistry of reaction products 30 and 31 were also unambiguously determined following a single-crystal X-ray analysis (Scheme 11).


Scheme 11: Synthesis of cis-vinylaziridines 30 and 31 from aldimines 14 and bromomethylbutenolide 29.

The stereoselective synthesis of diastereomeric 2-chloro-2-aroylaziridines 36 and 32 was successfully accomplished through a three-component cascade coupling reaction of silyldichloromethanes 33, arylnitriles 34 and chiral N-tert-butanesulfinyl aldimines (RS)-14. The process reported by Lu, Xu and co-workers started with the deprotonation of silyl compounds 33 with LDA at –78 °C, leading to the corresponding silyldichloromethyllium derivative, which reacted with arylnitrile 34. After nucleophilic addition and [1,3]-aza-Brook rearrangement, N-silyllithiumenamide 35 was formed. This strongly nucleophilic species could be traped by the chiral imine (RS)-14, producing 2-chloro-2-aroylaziridines via and aza-Darzens reaction [73]. Importantly, the structure of the final aziridine is determined by the silyl group, and the order of the addition of HMPA and imine 14 in the multicomponent coupling. When the bulky TBS group was used, and HMPA was added to the reaction mixture before the imine 14, aziridines 36 were formed. The addition of lithium metaloenamine took place through and open transition state to the Re face of the imine (RS)-14, followed by an intramolecular nucleophilic substitution to form the aziridines ring. On the contrary, aziridines 32 were obtained starting from dichloromethyltrimethylsilane (33, [Si] = TMS), and adding the chiral imine before HMPA to the reaction mixture. The nucleophilic addition of metaloenaime occurred through a cyclic transition state to the Si face of the imine (RS)-14. In this way, both cis-aziridines diastereoisomers 36 and 32 were formed from the same chiral imine 14 and arylnitriles 34 (Scheme 12).


Scheme 12: Synthesis of 2-chloro-2-aroylaziridines 36 and 32 from aldimines 14, arylnitriles 34, and silyldichloromethanes 33, and proposed transition states.

Chiral sulfinyl imines have been also used in the stereoselective synthesis of aziridines. The reaction of N-tert-butanesulfinyl trifluoromethyl ketimines (SS)-37 with dimethylsulfoxonium methylide 38 gave trifluoromethylated aziridines 39 in moderate to excellent yields (45–93%), and good diastereoselectivities (86:14 to >99:1 dr). The absolute configuration of compounds 39 was determined by X-ray crystallographic analysis, and it was found that the configuration of the newly generated stereocenter was R. Huang and co-workers proposed a cyclic transition state determined by the coordination of the nitrogen of the imine, and the oxygen atoms of the sulfoxonium and sulfinyl units to the sodium cation, which is present in the reaction medium [74]. The trifluoromethyl group occupies an equatorial position to avoid electrostatic repulsion with the lone pair of electrons of the sulfinyl group. The nucleophilic attack took place to the Si face of the ketimine 37 (Scheme 13).


Scheme 13: Synthesis of trifluoromethylaziridines 39 and proposed transition state of the aziridination.

Recently, Yang and co-workers described the diastereoselective synthesis of aziridines 42 in one-step using the Cu(I)/ʟ-proline complex as a catalyst and N-tert-butasulfinylamide in an aminotrifluoromethylation reaction of alkenes. All the aziridines 42 were obtained with high diastereoselectivity (dr > 25:1) and good yields (56–98%) from allylic sulfonamides 40 and Togni’s reagent (41). The reaction mechanism is proposed based on DFT calculations. In this study, they observed an intramolecularly intermediate Cu(III) species, and the sulfinamide acts as a direction group and nucleophile [75] (Scheme 14).


Scheme 14: Synthesis of aziridines 42 and proposed state transition.

Asymmetric synthesis of azetidines

Azetidine [76,77] has attracted less attention than aziridines, pyrrolidines and piperidines, among small and medium size aza-heterocycles, because there are no general methods for their preparation. However, four-membered nitrogen-containing heterocycles have recently found applicability in pharmacy as highly biological active compounds. Among this group of nitrogenated heterocycles, β-lactams (azetidin-2-ones) have reached especial attention [78-80], being easily accessible from β-aminoesters.

A stereoselective synthesis of 1-substituted 2-azaspiro[3.3]heptanes 45 (n = 1) was reported by the group of Reddy [81] starting from ethyl cyclobutanecarboxylate 43 and chiral N-tert-butanesulfinyl aldimines (RS)-14. In this three-step procedure, a highly diastereoselective addition of the ethyl cyclobutanecarboxylate anion occurred first, followed by the reduction of the ester group, and an intramolecular nucleophilic substitution of the tosylate of the resulting primary alcohol (Scheme 15). This methodology was applicable to the synthesis of 1-phenyl-2-azaspiro[3.4]octane (45, n = 2, R = Ph) and 1-phenyl-2-azaspiro[3.5]nonane (45, n = 3, R = Ph). The structure and absolute stereochemistry of these compounds were assigned based on the single-crystal X-ray diffraction analysis of azaspiroheptane 45 with a 9-fenanthryl substituent at 1-position.


Scheme 15: Synthesis of 1-substituted 2-azaspiro[3.3]heptanes, 1-phenyl-2-azaspiro[3.4]octane and 1-phenyl-2-azaspiro[3.5]nonane 45 from chiral imines 14, and ethyl cycloalkanecarboxylates 43.

The same three-step procedure was applied by Reddy and co-workers to synthesize 1-substituted 2,6-diazaspiro[3.3]heptanes 48, starting in this case from 1-Boc-azetidine-3-carboxylate 46, instead of ethyl cyclobutanecarboxylate 43 [82]. This structural motif was found to have similar physicochemical properties as 2-substituted piperazines, which are key intermediates in drug discovery. The applied protocol was found to be practical for the asymmetric synthesis of a variety of aromatic, heteroaromatic, and aliphatic 1-substituted 2,6-diazaspiro[3.3]heptanes 48, with overall yields ranging from 74 to 94% (Scheme 16).


Scheme 16: Synthesis of 1-substituted 2,6-diazaspiro[3.3]heptanes 48 from chiral imines 14 and 1-Boc-azetidine-3-carboxylate (46).

Asymmetric synthesis of β–lactams

β-Lactam antibiotics are important drug class of antibacterial agents [83] and in the literature, several strategies are reported using the sulfinyl group [84-88]. In this context, an enantioselective synthesis of 4-substituted azetidin-2-ones 52 was also accomplished starting from chiral imines 14 and dimethyl malonate (49). A diastereoselective coupling of these components under solvent-free conditions was carried out, using sodium carbonate as base promoter. The resulting dimethyl 2-(1-aminoalkyl)malonates 50 were obtained in moderate to good yields as single diastereoisomers in all cases except for aromatic aldimines. Compounds 50 could be easily transformed successively into β-amino esters 51, and the corresponding β-lactams 52 with high optical purity (Scheme 17) [89]. The absolute configurations of compounds 52 were obtained by the comparison of the signs of specific rotation of 52 with R = Ph(CH2)2, with that of known (R)-4-(2-phenylethyl)azetidin-2-one. A 6/4-fused bicyclic transition state model was proposed to rationalize the stereochemical outcome, in which the sodium metal is chelated by the oxygen and the nitrogen atoms of sulfinyl imine (Scheme 17), occurring the nucleophilic attack to the Si face of the imines with RS configuration.


Scheme 17: Synthesis of β-lactams 52 from chiral imines 14 and dimethyl malonate (49).

Su and Xu reported the stereoselective synthesis of spiro β-lactam 57 from chiral (RS)-N-tert-butanesulfinyl isatin ketimine 53 (R1 = H), with a bulky trityl protecting group bonded to the nitrogen indolic atom (Tr = triphenylmethyl), and ethyl bromoacetate. The Zn/Cu-mediated Reformatsky-type reaction furnished enantiomerically pure compound 54 after column chromatographic purification. Selective desulfinylation of 54 was carried out by using 1.0 M HCl in EtOAc, and further removal of the Tr group by the employment of TFA in dichloromethane afforded the 2-oxoindolinyl amino ester derivative 55, the key intermediate for the synthesis of (–)-AG-041R, a gastrin/cholecyctokinin-B receptor antagonist. In addition, amino ester 55 was transformed into the fully unprotected amino acid 56 under basic conditions in MeOH, and after that, further treatment with of MsCl and NaHCO3 in MeCN at 80 °C led to spiro-β-lactam derivative 57 in 72% combined yield (Scheme 18) [88].


Scheme 18: Synthesis of spiro-β-lactam 57 from chiral (RS)-N-tert-butanesulfinyl isatin ketimine 53 and ethyl bromoacetate.

In 2020, Pierce and co-workers developed a method for the synthesis of guanidinium alkaloid batzelladine D in enantiomeric and racemic form, along with a series of stereochemical analogues. The batzelladines are a family of polycyclic guanidinium alkaloids that were isolated in the mid-1990s from the Caribbean sponge bataella sp. From a biological point of view, the batzelladines have received attention due to their reported activity as inhibitors of HIV gp120-human CD4 binding. Chiral N-tert-butanesulfinyl aldimine (SS)-58 was used as a precursor in the synthesis of (–)-batzelladine D 61 and (–)-13-epi-batzelladine D 62. The reaction of (SS)-58 with methyl bromoacetate in the presence on Zn and CuCl in THF, left, after removal of the sulfinyl group under acidic conditions, to β-amino ester ammonium chloride 59 in high yield. This compound was transformed into β-lactam 60 in 90% yield by treatment with LDA in THF at −78 °C [90]. Compound 60 was converted after 9 steps in target batzelladines D 61 and 62 (Scheme 19). The authors explored also the antimicrobial activity of these compounds against a series of pathogens with starting promising results.


Scheme 19: Synthesis of β-lactam 60, a precursor of (−)-batzelladine D (61) and (−)-13-epi-batzelladine D (62) from chiral (SS)-N-tert-butanesulfinyl imine 58, and antimicrobial evaluation of MCI values for these compounds.

Asymmetric synthesis of pyrrolidines

The pyrrolidine ring is more represented within natural products than the 3- and 4-membered nitrogen-containing heterocycles. This molecular array is also found in drugs and other biologically active molecules. For this reason, there are numerous examples of synthetic methodologies for these compounds in the literature. In most cases, the pyrrolidine ring is formed from an amine with a hydrocarbon chain that also carries a functional group at the appropriate distance that allows the cyclization process to take place. In the case of substituted pyrrolidines, the stereoselective synthesis is especially interesting, highlighting the 1,3-dipolar cycloaddition reactions with azomethine ylides as an example of transformation that take place with great stereocontrol, and allow the synthesis of polyfunctionalized pyrrolidines in a single reaction step [91,92]. On the other hand, natural amino acids proline and hydroxyproline are functionalized pyrrolidines that have found great application in organic synthesis as chiral organocatalysts in stereoselective processes [93,94].

Cyclizations involving a position in the starting chiral imine

Arylation of chiral sulfinyl imines with sodium tetraarylboronates 64 was found to proceed with high diastereoselectivity under rhodium catalysis. Reddy and co-workers applied this methodology to the synthesis of 2-substituted pyrrolidines 66 [95]. The arylation of chlorinated imine (RS)-63 was performed with 2 mol % of an air-stable rhodium catalyst in dioxane, in the presence of 2 equivalents of MeOH, at 65 °C, leading to compounds 65 with high diastereomeric ratio. Crude amides 65 were converted into the corresponding pyrrolidines 66 in high yield by stirring at room temperature for 1 h in presence of 2.0 equivalents of LiHMDS (Scheme 20). It is important to highlight that cyclization occurred without epimerization with such as strong base.


Scheme 20: Rhodium-catalyzed asymmetric synthesis of 3-substituted pyrrolidines 66 from chiral imine (RS)-63 and sodium tetraarylborates 64.

Isoindolines with substituents at 1 and 3 positions were synthesized from an aromatic N-tert-butanesulfinyl imine 67, bearing a Michael acceptor in the ortho-position. Fustero, Barrio and co-workers found that combining an asymmetric nucleophilic addition to the chiral imine, with an intramolecular conjugate aza-Michael reaction, the expected 1,3-disubstituted isoindolines were produced with high diastereoselectivity [96]. Importantly, depending on the base involved in the intramolecular aza-Michael reaction, it was possible to reach either cis- or trans-isoindolines, 69 and 70, respectively, from the same precursor 68. The authors proposed that the thermodynamically more stable cis-isomer 69 is formed when TBAF was used. Meanwhile, working under kinetic conditions (DBU as base), trans-isomer 70 was obtained (Scheme 21).


Scheme 21: Asymmetric synthesis of 1,3-disubstituted isoindolines 69 and 70 from chiral imine 67.

The group of Stahl provided an elegant approach to the synthesis of 2,5-disubstituted pyrrolidines 73, from alkenyl sulfinamides 72 [97]. These substrates were prepared from chiral N-tert-butanesulfinyl imine (RS)-71. Nucleophilic additions to this imine took place with high diastereoselectivity to the Si face of the iminic carbon. After that, the combination of Pd(TFA)2, lithium acetate and DMSO as solvent led to optimal results in the oxidative cyclization process to produce pyrrolidines 73 as a single diastereoisomer, with relative cis-configuration (Scheme 22). This has been the first reported nucleophilic attack of the sulfinyl group to a π-allylpalladium intermediate.


Scheme 22: Asymmetric synthesis of cis-2,5-disubstituted pyrrolidines 73 from chiral imine (RS)-71.

The asymmetric synthesis of 3-hydroxy-5-substituted pyrrolidin-2-ones 77, with relative cis-configuration, was reported by the group of Huang and Wei [98]. A diastereoselective addition of Grignard reagents to chiral aldimine (RS)-74, and an intramolecular oxidative cyclization of aminoalcohols derivatives 76, are key steps of this approach. Both diastereoisomers of aldimines 74 (RS and SS) were prepared from ᴅ-malic acid and the corresponding enantiomer of tert-butanesulfinamide. Importantly, the choice of the solvent was crucial for obtaining high diastereoselectivities in the Grignard addition step, in which dichloromethane was performing better than THF. On the other hand, diastereoselectivities for addition products 75 were higher working with (RS)-74 than its (SS) diastereoisomer, indicating a mismatch between the chiral auxiliary and the stereocenter in this substrate. Concerning the oxidative cyclization reaction, pyridinium dichromate (PDC) provided low yields of expected lactam 77. Many oxidants were checked for this transformation to take place, and the Sarett reagent [CrO3·(C5H5)2] in DMF was the best to produce lactams 77. The synthetic interest of these functionalized lactams was demonstrated in the synthesis of alkaloid (−)-preussin (78) from the appropriate precursor 77 in three steps (Scheme 23).


Scheme 23: Asymmetric synthesis of 3-hydroxy-5-substituted pyrrolidin-2-ones 77 from chiral imine (RS)-74.

Similar strategies were employed to obtain similar heterocycles [99]. Other regio- and stereoisomeric 2-pyrrolidones 80 were also prepared by a stereoselective tandem Barbier process of 79 with alkyl and aryl bromide [100]. The process was performed in this case under Barbier reaction conditions. Namely, the formation of the nucleophile (organomagnesium reagent) is carried out in the presence of the electrophile (chiral imine 79). Surprisingly, both diastereomeric aldimines 79 (RS and SS) gave similar results concerning the stereochemical outcome, suggesting that the chiral sulfonamide moiety was not involved in the stereocontrol during this tandem Barbier addition process. After addition of the organomagnesium reagent to the imine 79, cyclization involving the magnesium amide and the ester occurred without the need of an extra cyclization step to give, after N-Boc protection, 4-hydroxy-5-substituted pyrrolidin-2-ones 90, with relative trans-configuration (Scheme 24).


Scheme 24: Asymmetric synthesis of 4-hydroxy-5-substituted pyrrolidin-2-ones 80 from chiral imines 79.

Cyclizations involving a position in the attacking nucleophile

The reaction of ethyl 4-bromocrotonate (81) with LDA at −78 °C and subsequent addition of chiral imines 14 afforded 3-pyrrolines 82 with high diastereoselectivity. Chogii and Njardarson proposed that after deprotonation of 81, the resulting dienolate reacted at α-position with the chiral imine 14. The addition was highly diastereoselective, being the configuration of the newly created stereogenic center dependent on the configuration of the sulfur atom of the starting imine 14. After nucleophilic addition, and subsequent elimination, 3-pyrrolines 82 were formed as single diastereomers [101]. The whole process could be considered a [3 + 2] annulation, and aziridines were not observed as competing reaction products (see above Scheme 11). In addition, hindered imines, ethers, sulfonates, heteroaryl substituents, and conjugated imines were all well tolerated (Scheme 25).


Scheme 25: Asymmetric synthesis of 3-pyrrolines 82 from chiral imines 14 and ethyl 4-bromocrotonate (81).

A SmI2-mediated coupling of allenoate 83 with chiral (RS)-14 provided γ-amino ester derivatives 84 in good yields and moderate diastereomeric ratios. Huang and Py found that the better yields and diastereoselectivities were found working in THF as solvent in the presence of t-BuOH and LiBr as additives [102]. The isopropyl-substituted derivative 84 was easily converted into the corresponding methylene lactam 85, upon removal of the sulfinyl unit under acidic conditions. Finally, ozonolysis of 85 yielded tetramic acid 86 in 60% yield (Scheme 26). The configuration of the newly generated chiral center in compounds 84 was assigned from the sign of the optical rotation of enantioenriched tetramic acid 86, which was previously characterized. Based on this, it can be stated that addition of the allenoate 83 takes place mainly to the Re face of imines with (RS)-configuration.


Scheme 26: Asymmetric synthesis of γ-amino esters 84, and tetramic acid derivative 86 from chiral imines (RS)-14 and allenoate 83.

Excellent diastereoselectivities were also achieved in the indium-mediated allylation of chiral tert-butanesulfinyl glyoxylate imine derivatives 87 with ethyl 2-bromomethylacrylate (88). Working at room temperature without any additional solvent provided the highest yields in these coupling reactions, amino diesters 89 being isolated as single diastereoisomers (Scheme 27). Removal of the sulfinyl group under acidic conditions, and further treatment of the resulting ammonium salts with sodium ethoxide, yielded α-methylene-γ-butyrolactams 90, in a one-pot, two-step process [103]. A six-membered chair-like transition state model with the indium coordinated to the nitrogen atom of the imine, and the sulfinyl and R groups located at axial positions, in a kind of s-cis conformation, was proposed to rationalize the stereochemical outcome. By considering this working model, the nucleophilic attack took place to the Re face of imines with (Z,SS)-configuration (Scheme 27).


Scheme 27: Asymmetric synthesis of α-methylene-γ-butyrolactams 90 from chiral imines (Z,SS)-87 and ethyl 2-bromomethylacrylate 88.

The cycloaddition of chiral sulfinyl imines (RS)-14 with 2-(trimethysilylmethyl)allyl acetate (91) could also be promoted by Pd(0) to give methylenepyrrolidines 92. The group of Stockman demonstrated that Pd(PPh3)4 was the best source of Pd(0) and that the reaction worked well in different solvents, with dry THF giving the best diastereoselectivities and good yields at room temperature [104]. The configuration of the major diastereoisomer was assigned by X-ray crystallographic analysis. From this, authors rationalized the stereochemical outcome of the cyclization considering that the stereoinduction is derived from the dipole–dipole repulsion of the sulfinyl imine, which places the tert-butyl group on the Si face, and thus the cycloaddition occurs from the less sterically hindered Re face. The cyclization process worked also in tert-butanesulfinyl ketimines, but yields and diastereoselectivities were significantly lower (Scheme 28).


Scheme 28: Asymmetric synthesis of methylenepyrrolidines 92 from chiral imines (RS)-14 and 2-(trimethysilylmethyl)allyl acetate 91.

Recently, a series of alkaloids like dibenzoazaspirodecanes 97 have been synthesized by addition of 2-bromobenzylmagnesium bromide (94) to chiral N-tert-butanesulfinyl imines 93. These reactions proceeded with high levels of diastereocontrol. The resulting sulfonamide derivatives 95 were transformed into the target spiro compound 97 by performing successive desulfinylation and intramolecular palladium-catalyzed N-arylation. To rationalize the stereochemical course of the addition, DFT calculations were performed and they predicted correctly the observed experimental results considering a six-membered ring cyclic transition state. The addition took place to the Si-face of the imines with (RS)-configuration. Compounds 97 were also evaluated in a preliminary study in leukemia strains (Scheme 29) [105].


Scheme 29: Synthesis of dibenzoazaspirodecanes from cyclic N-tert-butanesulfinyl imines.

Li and Xu reported a method for the enantioselective synthesis of β,γ-unsaturated α-amino acids 100, by a Lewis acid-promoted diastereoselective Petasis reaction of vinylboronic acids 98, (R)-N-tert-butanesulfinamide and glyoxylic acid (99). They found that the best results were obtained working with InBr3 as Lewis acid, in dichloromethane at room temperature [106]. Under these reaction conditions, sulfinyl imine is formed first along with the boronate by interaction of the corresponding vinylboronic acid with the carboxylic group of the imino acid intermediate. The transfer of the vinyl unit to the electrophilic iminic carbon took place in a quite rigid system, with chelation of the Lewis acid with the nitrogen of the imine and carboxylate oxygen, forming a five-membered ring. The migration of the vinyl group occurred to the Re face of the imine, which is less shielded than the Si face, because of the influence of the bulky tert-butyl in the most stable conformation of the sulfinyl imine (Scheme 30). The authors also demonstrated the synthetic utility of compounds 100. Their reaction with thionyl chloride in methanol produced removal of the sulfinyl group and formation of the corresponding methyl ester, to give compounds 101. Subsequent, reductive ammination with 3-phenyl-2-propynal led to reaction intermediates 102, which under typical Pauson–Khand reaction conditions gave cyclopenta[c]proline derivatives 103 in moderate yields, with high diastereoselectivities (Scheme 30).


Scheme 30: Stereoselective synthesis of cyclopenta[c]proline derivatives 103 from β,γ-unsaturated α-amino acids 100.

Asymmetric synthesis of piperidines

The six-membered nitrogen-containing rings are the most common heterocycles among natural products and also synthetic pharmaceutical drugs [107,108]. For this reason, the piperidine unit has attracted great attention among organic chemists [109]. Due to that, a large number of classical methodologies have been used for their synthesis, in which the key step is the generation of the six-membered ring, including the aldol reaction, the reductive amination, Mannich reaction, ring closing metathesis, Diels–Alder reaction with imines as dienophiles, aza-Prins cyclization, and intramolecular Michael reaction, among others [110-115]. Despite the considerable effort made to date in this field, the development of new methodologies that allow accessing these heterocycles in a stereoselective way, and taking into account environmental considerations as one of the most important points, continue to be of great interest [109,116-118].

Cyclizations involving a position in the starting chiral imine

Enantiomeric N-tert-butanesulfinyl imines 104b derived from 3-(2-bromophenyl)propanal have been used as reaction intermediates in the synthesis of tetrahydroquinoline alkaloids (−)-angustureine (107) and (−)-cuspareine (108) reported by Sirvent et al. [119]. The diastereoselective addition of a Grignard reagent was a key step in this methodology. The addition proceeded with high diastereoselectivity in toluene, and the attack of the Grignard reagent occurred on the Re face of the imine with S configuration at the sulfur atom, through a chelated transition state. The reaction of chiral aldimine (SS)-104b with pentylmagnesium bromide gave compound 106 in 75% yield. Further successive N-desulfinylation, intramolecular palladium-catalyzed N-arylation, and final N-methylation led to (−)-angustureine (107) in high overall yield (Scheme 31). The same methodology was applied to the synthesis of (−)-cuspareine (108), starting in this case from enantiomeric imine (RS)-104b, and using 2-(3,4-dimethoxyphenyl)ethylmagnesium bromide as Grignard reagent.


Scheme 31: Stereoselective synthesis of alkaloids (−)-angustureine (107) and (−)-cuspareine (108).

A straightforward synthesis of the alkaloid (−)-pelletierine (112) was accomplished by the diastereoselectivity coupling of 3-oxobutanoic acid (110) and the N-tert-butanesulfinyl imine (RS)-109 derived from 5-bromopentanal (114). The base-promoted decarboxylative-Mannich coupling of these reagents led to β-amino ketone derivative 111, which was not isolated. After removal of the sulfinyl group under acidic conditions, and intramolecular N-alkylation upon treatment with sodium bicarbonate, (−)-pelletierine (112) was formed, and easily isolated as its hydrochloride derivative (Scheme 32) [120]. Compound 112 is a key intermediate in the biomimetic synthesis of natural alkaloids. Interestingly, amino allylation of 5-bromopentanal (114) with (R)-tert-butanesulfinamide and allyl bromide (113, R = H) in the presence of indium metal gave homoallylamine derivative 115. In this transformation, imine (RS)-109 is a reaction intermediate that was not isolated. Treatment of 115 with potassium hexamethyldisilazide (KHMDS) led to the sulfinyl piperidine derivative 116, and final deprotection under acidic conditions produced enantioenriched 2-allylpiperidine (117) as its hydrochloride (Scheme 32) [121]. Compound 117 has been also an advanced intermediate in the synthesis of alkaloids. For instance, hydrogenation of 117 yielded (+)-coniine (118), the major alkaloid extracted from poison hemlock and responsible for its toxicity, as its hydrochloride, and N-Boc protected derivative of 117 submitted to Wacker oxidation led to (−)-pelletierine (112) alkaloid.


Scheme 32: Stereoselective synthesis of alkaloids (−)-pelletierine (112) and (+)-coniine (117).

Yus and co-workers developed the synthesis of the piperidine alkaloids (+)-dihydropinidine (122a), (+)-isosolenopsin (122b), (+)-isosolenopsin A (122c) and (2R,6R)-6-methylpipecolic acid hydrochloride by oxidation of the aromatic ring of (2R,6R)-2-methyl-6-phenylpiperidine (122d). The diastereoselective allylation of (SS)-N-tert-butanesulfinyl imines 119 mediated by indium metal under Barbier's reaction connections (formation of the allylindium intermediate in the presence of the imine electrophile) is the key step in these syntheses (Re-face attack). The natural products were obtained after four additional steps: cross-metathesis of allylated compounds 120 with methyl vinyl ketone, reduction of conjugated C=C double bond, removal of the sulfinyl group under acidic conditions, and final stereoselective reduction of the imine formed by intramolecular cyclization (Scheme 33) [122].


Scheme 33: Synthesis of piperidine alkaloids (+)-dihydropinidine (122a), (+)-isosolenopsin (122b) and (+)-isosolenopsin A (122c) .

The group of Prasad reported the diastereoselective synthesis of β-amino ketone derivatives from N-tert-butanesulfinyl imines and silyl enol ethers of aryl methyl ketone [123]. The synthetic interest in β-amino ketones was exemplified in the synthesis of alkaloid (+)-sedamine (125), which has been shown to display memory-enhancing properties and was also effective for the treatment of cognitive disorders. The reaction of the N-tert-butanesulfinyl imine (SS)-119 with trimethylsilyl enol ether derived from acetophenone 123 in the presence of TMSOTf at low temperature, produced β-amino ketone derivative 124 in high yield and diastereoselectivity (Scheme 34). A reduction of 124 gave a mixture of diastereomeric alcohols, and the one with (R)-configuration at the benzylic position was isolated in 54% yield. Further treatment of the alcohol with NaH furnished a cyclized product, which after desulfination and N-methylation led to expected (+)-sedamine (125) in 30% overall yield from ketone derivative 124.


Scheme 34: Stereoselective synthesis of the alkaloids(+)-sedamine (125) from chiral imine (SS)-119.

The stereoselective synthesis of trans-5-hydroxy-6-substituted-2-piperidinones was also reported by the group of Wei, taking advantage of the addition of Grignard reagents to N-tert-butanesulfinyl α-alkoxy aldimines 126 [124]. In this one-pot approach, a successive nucleophilic addition–cyclization–desulfinylation took place, leading directly to piperidinones 127. The reactions were performed in THF at −78 °C for 3 hours. Yields ranged from moderate to excellent with aliphatic and aromatic organomagnesium compounds. Based on X-ray crystallographic analyses, the relative configurations of the products 127 were unambiguously assigned as trans-form. The stereocontrol was governed by the stereogenic center bearing the OTBS group at α-position of the imine, showing no influence on it the configuration of the sulfur atom of the sulfinyl unit. This methodology was applied to the asymmetric synthesis of (−)-CP-99,994 (128), the enantiomer of a promising clinical agent which displays a variety of biological activities, including neurogenic inflammation, pain transmission, and regulation of the immune response. Starting from α-alkoxy aldimines ent-126, the utility of this methodology was also demonstrated in the synthesis of alkaloid (+)-cassine (130), isolated from the leaves and twigs of Cassia excelsa, displaying antimicrobial activity. Methylmagnesium bromide was the Grignard reagent in this synthesis, with a 18% overall yield after seven steps from aldimine ent-126 (Scheme 35) [125].


Scheme 35: Stereoselective synthesis of trans-5-hydroxy-6-substituted-2-piperidinones 127 and 129 from chiral imines 126.

The reaction of chiral α-siloxyl imine (SS)-126 with enolates derived from methyl ketones 131 was also investigated. The enolate was formed with LDA at −78 °C and reacted at the same temperature with imine (SS)-126 for 2.5 hours. The addition proceeded with high diastereoselectivity, followed by cyclization. Final acid treatment produced the removal of the sulfinyl group leading to trans-5-hydroxy-6-substituted ethanone-2-piperidinones 132 in moderate to high yields, as a single diastereoisomer [126]. The diastereoselectivity of the addition was controlled in this case by both the α-siloxyl group and the chiral sulfinamide moiety. Interestingly, the utility of this approach was also demonstrated by the synthesis of (+)-febrifugine (133), a natural product isolated from Chinese medicinal plants Dichroa febrifuga Lour., and (+)-halofuginone (134), which is a pharmaceutical candidate developed from febrifugine for the treatment of human scleroderma (Scheme 36).


Scheme 36: Stereoselective synthesis of trans-5-hydroxy-6-substituted ethanone-2-piperidinones 132 from chiral imine (SS)-126.

The reaction of chiral imine 135 with Grignard reagents in THF took also place with high diastereoselectivity. Starting imine 135 with two well-defined stereogenic centers at the hydrocarbon backbone were prepared as a mixture of (RS)- and (SS)-diastereoisomers from ᴅ-glutamic acid. After nucleophilic addition to the imine, a successive cyclization–desulfinylation occurred to give the corresponding piperidinone. Final reaction with di-tert-butyl dicarbonate led to functionalized 2-piperidinones 136 [127]. These compounds are interesting reaction intermediates because they can be transformed by conventional reactions into, for instance, compound L-685,458 (137), an inhibitor of γ-secretase, with potential interest for the treatment of Alzheimer’s disease and other neurological disorders (Scheme 37).


Scheme 37: Stereoselective synthesis of trans-3-benzyl-5-hydroxy-6-substituted-2-piperidinones 136 from chiral imines 137.

The diastereoselective synthesis of trans-5-hydroxy-6-substituted 2-piperidinones 139 was also achieved from O-benzyl protected aldimine 138 following the previously commented tandem Grignard reagent addition, subsequent cyclization-desulfinylation, and final N-Boc protection. The stereochemical pathway is controlled exclusively again by the configuration of the stereogenic center bearing the benzyloxy group [128]. Interestingly, chiral δ-lactams 139 are synthetic intermediates that can be transformed into compound (+)-L-733,060 (140), a potent neurokinin substance P receptor antagonist. This compound displays a wide variety of biological activities, including inhibition of neurogenic inflammation, blocking of pain transmission and regulation of immune response (Scheme 38).


Scheme 38: Stereoselective synthesis of trans-5-hydroxy-6-substituted 2-piperidinones 139 from chiral imine 138.

A stereoselective synthesis of ʟ-hydroxypipecolic acid 145 was reported recently by Zhang and Sun. Compound 145 is an intermediate for the synthesis of β-lactamase inhibitors. A key step in this synthesis was the hydrocyanation of chiral sulfinyl imine 141, prepared from commercially available and inexpensive ʟ-glyceraldehyde acetal, with trimethylsilyl cyanide (TMSCN) in THF at −10 °C. The reaction product 142 was obtained in quantitative yield and good diastereomeric ratio. Further hydrolysis of the cyclic acetal, and subsequent epoxidation of the resulting diol under typical Mitsunobu conditions led to epoxide derivative 143. The piperidine ring was formed through a 6-endo-tet cyclization by treatment of the epoxide 143 with sodium carbonate in toluene at 80 °C. Hydrolysis of the cyano group under acidic conditions of compound 144 led to expected ʟ-hydroxypipecolic acid hydrochloride 145 in high yield (Scheme 39) [129].


Scheme 39: Stereoselective synthesis of ʟ-hydroxypipecolic acid 145 from chiral imine 144.

In 2018, Wei and co-workers described the diastereoselective synthesis of 1-substituted isoquinolones using one-pot addition–cyclization–deprotection of the imine with Grignard reagents [130]. In this work, the addition to chiral imines 146, 148 and 150 was performed using 2,2’-dipyridyl- or 4-methylmorpholine (NMM) to promote the complexation with the Grignard reagent. Products 147 and 149 were obtained in excellent yields and high diastereoselectivity and when 4-methylmorpholine (NMM) was used as additive, the heterocycle 151 was obtained in one pot addition–cyclization–deprotection of imine 150 (Scheme 40).


Scheme 40: Synthesis of 1-substituted isoquinolones 147, 149 and 151.

In 2020, Kaczorek and Kawęcki described the stereoselective synthesis of 3-substituted dihydrobenzo[de]isoquinolones 154 in both enantiomeric forms in one step. In this study, they reported an addition–cyclization–substitution reaction employing (Rs) and (Ss) N-tert-butylsulfinyl imine 14 and Grignard reagents using THF or CH2Cl2 as solvent at 40 °C. The 3-substituted dihydrobenzo[de]isoquinolinones 154 were obtained with good yield and with enantiomeric excess of 46–99%. The mechanism was explained by stereoselective addition of the Grignard reagent to the N-sulfinyl imine 153a derived from 152, in a subsequent cyclization to obtain the intermediate 156 then, a substitution at the sulfur atom occurred to form 154a and 157 [131] (Scheme 41).


Scheme 41: Stereoselective synthesis of 3-substituted dihydrobenzo[de]isoquinolinones 154.

In 2017, Reddy and co-workers described the stereoselective synthesis of (S)-1-benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (163), (S)-1-benzyl-6,7-dimethoxy-N-methyl-1,2,3,4-tetrahydroisoquinoline (164), (−)-O,O-dimethylcoclaurine (165) and (+)-O-methylarmapavine (166) alkaloids via chiral tert-butylsulfinamide through a haloamide cyclization. The strategy was based on the addition of organomagnesium bromide or chloride to chiral N-sulfinyl imine 160. A subsequent base promoted cyclization of chloroamides (158 and 162) and the products 165 and 163 were obtained in 91% and 93% yields respectively. The N-methylation of alkaloids 163 and 165 using 37% formaldehyde and sodium borohydride formed the tetrahydroisoquinoline 164 and 166 in high yields of 95% and 94%, respectively [132] (Scheme 42).


Scheme 42: Enantioselective synthesis of alkaloids (S)-1-benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (163), (S)-1-benzyl-6,7-dimethoxy-N-methyl-1,2,3,4-tetrahydroisoquinoline (164), (−)-O,O-dimethylcoclaurine (165) and (+)-O-methylarmapavine (166).

Pinto and co-workers reported recently the enantioselective synthesis of natural alkaloids (−)-cermizine B 171 and (+)-serratezomine E 172. A key step of the synthetic strategy is the allylation with allylmagnesium bromide of N-tert-butanesulfinyl imine 168. At the allylation step, a new chiral center with S configuration in compound 169 is formed in 96% yield. After removal the chiral sulfinyl group under acid conditions, treatment with acryloyl chloride produced acrylamide derivative 170. From this common intermediate, and after several subsequent steps, including ring-closing metathesis [133], (−)-cermizine B (171) and (+)-serratezomine E (172) were obtained 57% and 72% yield, respectively (Scheme 43) [134,135].


Scheme 43: Enantioselective synthesis of alkaloids (−)-cermizine B (171) and (+)-serratezomine E (172) developed by Pinto and co-workers.

Cyclizations involving a position in the attacking nucleophile

Isosolenopsin (177) and solenopsin (178) are two isomeric piperidine alkaloids isolated from fire ants (Solenopsis) and display hemolytic, insecticide and antibiotic properties. A straightforward synthesis of these natural products from a common imine intermediate was reported by Medjahdi et al. comprising as key steps the indium–titanium-mediated aminoallylation of nonanal with (R)-tert-butanesulfinamide and allyl bromide, giving rise homoallylamine derivative 173, a subsequent cross metathesis with methyl vinyl ketone (174) catalyzed by Hoveyda–Grubbs second generation catalyst to produce compound 175, followed by hydrogenation–desulfynation, and final stereoselective reduction of the resulting cyclic imine intermediate 176. In this diastereodivergent approach, reduction of this imine with sodium borohydride in a citrate-phosphate buffer medium (pH 5) led to (+)-isosolenopsin (177) in 93% yield and >98:2 cis/trans selectivity. On the other hand, when the reduction of imine 177 was carried out applying H. Yamamoto’s protocol (AlMe3/LiAlH4), (+)-solenopsin (178) was isolated in 83% yield and with excellent diastereoselectivity (>98:2 trans/cis selectivity, Scheme 44) [136].


Scheme 44: Stereoselective synthesis of (+)-isosolepnosin (177) and (+)-solepnosin (178) from homoallylamine derivative 173.

There are many compounds with a 1,2,3,4-tetrahydroisoquinoline structural motif bearing substituents at 1-position which display a wide range of biological activities. However, compounds bearing substituents at 3-position are less represented in nature and among pharmaceutical drugs. A multistep methodology to synthesize 1,2,3,4-tetrahydrosioquinolines 185 bearing substituents at 3-, 6- and 7-positions in a highly enantioselective fashion starting from chiral N-tert-butanesulfinyl imines (RS)-14 was reported by Sirvent et al. [137]. The key step of this synthesis is a [2 + 2 + 2] cyclotrimerization by means of Wilkinson catalyst of azadiyne system 180, which was accessible from imine 14 by consecutive diastereoselective indium-promoted propargylation, selective N-propargylation and final oxidation of the sulfinyl group. Sulfinyl imines (RS)-14 could be also precursors of tetrahydroisoquinolines with substituents at different positions of the aromatic ring, by combining allylation and propargylation processes as the first steps of this new strategy. The resulting azaenynes 179 and 181 were efficiently transformed by a ruthenium-catalyzed ring-closing metathesis into cyclic 1,3-dienes 182 and 186, respectively. The best results were obtained by performing the metathesis with Hoveyda–Grubbs second generation catalyst in the synthesis of cyclodiene 182, and with Grubbs first generation catalyst for compound 186. When these dienes reacted with dimethyl acetylenedicarboxylate in toluene at 100 ºC, followed by dehydrogenation of the resulting [4 + 2] adduct with DDQ, the expected 7,8- or 5,6-bis(methoxycarbonyl)substituted 1,2,3,4-tetrahydrosioquinolines 184 and 187, were obtained, respectively (Scheme 45).


Scheme 45: Stereoselective synthesis of tetrahydroquinoline derivatives 184, 185 and 187 from chiral imines (RS)-14.

Many indole alkaloids have been known for years and used in ancient cultures as psychotropic, stimulants and poisons. On the other hand, benzofurans and indoles, with a 2-aminoalkyl substituent at the 2-position, are not common compounds nor are they represented in nature. For that reason, synthetic methodologies to access these systems are of interest in order to explore their biological activity. Homopropargylamine derivatives 188 were obtained in a highly diastereoselective fashion (>95:5 dr) by nucleophilic addition of allenylindium intermediate to chiral N-tert-butanesulfinyl imines 14. Subsequent Sonogashira coupling of compounds 188 with o-iodophenol (X = O) or o-iodoaniline (X = NH) 189, led to 2-(2-aminoalkyl)benzofuran (X = O) and -indole (X = NH) derivatives 191. Further removal of the sulfinyl unit under acidic conditions produced amine derivatives 192, which were transformed into tetrahydropyrido-benzofuran (X = O) and indole (X = NH) derivatives 193 with relative cis-configuration, upon reaction with aldehydes. This Pictet–Spengler condensation was facilitated by the nucleophilic character of the 3-position of the benzofuran or indole moiety (Scheme 46) [138].


Scheme 46: Stereoselective synthesis of pyridobenzofuran and pyridoindole derivatives 193 from homopropargylamine derivatives 192.

Turlington and co-workers reported a stereoselective synthesis in three steps of 2-substituted 1,2,5,6-tetrahydropyridines 196 starting from chiral N-tert-butanesulfinyl imines (RS)-14 [139]. The synthesis commenced with addition of the organolithium compound resulting from the deprotonation of 4-chloro-1-butyne (194) to the imine. The propargylamine derivatives 195 were obtained in high yields and diastereoselectivities (>20:1 dr, in most cases). The lowest diastereoselectivity was found for pyridyl-substituted imine 14 (R = 3-pyridyl, 4:1 dr), due probably to competitive coordination of the lithium acetylide by the heteroatoms present in these imines. Reduction of the triple bond with Lindlar catalyst to provide olefin with cis-configuration, and cyclization using LiHMDS led to 1,2,5,6-tetrahydropyridines 196 (Scheme 47).


Scheme 47: Stereoselective synthesis of 2-substituted 1,2,5,6-tetrahydropyridines 196 from chiral imines (RS)-14.

Many methods have been provided to generate thermodynamically stable cis-2,6-disubstituted piperidines, but the synthesis of trans-derivatives remains elusive. In this regard, Bhattacharjee and co-workers reported a highly efficient large-scale synthesis of 2,6-trans-piperidine derivative 199 from easily available starting material [140]. Key steps of the synthesis are the diastereoselective addition of 4-pentenylmagnesium bromide to chiral imine (SS)-14 (R = 4-BrC6H4). Two diastereoisomers 197 were isolated in 94% yield and moderate diastereoselectivity. The major component of the mixture was transformed into compound 198 through a Hoveyda–Grubbs second generation cross metathesis with ethyl acrylate. Another key step was the intramolecular aza-Michael reaction promoted by cesium carbonate as base in dimethylacetamide (DMA), leading to 2,6-trans-piperidine derivative 199 in high yield (Scheme 48). This compound was an intermediate in the synthesis of a novel class of anti-infective agents.


Scheme 48: Stereoselective synthesis of 2-substituted trans-2,6-disubstituted piperidine 199 from chiral imines (SS)-14 (R = 4-BrC6H4).

The base-promoted decarboxylative Mannich coupling of chiral imines (RS)-14 [derived from an aldehyde R1CHO and (R)-tert-butanesulfinamide] with these reagents provided β-amino ketone derivative 200 in high yields and diastereoselectivities [120]. These compounds were easily transformed into cis-2,6-disubstituted piperidin-4-ones 201 through a ʟ-proline organocatalyzed intramolecular Mannich reaction with a second aldehyde (R2CHO). Almost no diastereoselectivity was observed when R1 and R2 were aromatic rings. On the other hand, aliphatic aldehydes gave in general excellent enantiomeric ratios (>90:10). It is important to note that the order of reaction of carbonyl compounds R1CHO and R2CHO with tert-butanesulfinamide to form chiral imine 14, or in the intramolecular organocatalyzed condensation, determined the absolute configuration of compounds 201 [141]. The usefulness of this methodology was demonstrated in the synthesis of the alkaloid (+)-241D (202), isolated from the skin of the Panamanian poison frog Dendrobates speciosus, through the reduction of piperidin-4-one 201 (R1 = Me, R2 = n-C9H19) with lithium borohydride (Scheme 49).


Scheme 49: Stereoselective synthesis of cis-2,6-disubstituted piperidines 200, and alkaloid (+)-241D, from chiral imines (RS)-14.

The base-catalyzed addition of 4-nitrobutanoates 203 to N-tert-butanesulfinyl imines (RS)-14 under solvent-free reaction conditions proceeded with high facial diastereoselectivity. The resulting β-nitroamine derivatives 204 were easily transformed into 5-nitro-6-substituted piperidine-2-ones 205, upon removal of the sulfinyl group with concomitant δ-lactam formation. Further transformation of the nitro group under Nef-type reaction conditions led to enantioenriched 6-substituted piperidine-2,5-diones 206 [142]. Interestingly, from compounds 205, and following a two-step process, involving conjugative addition to ethyl acrylate with formation of 207 as a single diastereoisomer, and final reduction of the nitro group with Raney-nickel, 1,7-diazaspiro[4.5]decane-2,8-diones 208 were accessed in a highly stereoselective fashion (Scheme 50) [143].


Scheme 50: Stereoselective synthesis of 6-substituted piperidines-2,5-diones 206 and 1,7-diazaspiro[4.5]decane-2,8-diones 208 from chiral imines (RS)-14.

A large number of biologically active natural products and synthetic pharmaceutical drugs contain the 3-aminooxidole motif. Chen and Xu demonstrated that the zinc-mediated allylation of chiral oxindole sulfinyl imines (RS)-53 with allylic bromides proceeded smoothly at room temperature in a mixture of THF and HMPA, and a wide range of highly enantiomerically enriched 3-allyl-substituted 3-aminooxindoles 209 were prepared. The observed diastereofacial selectivity was rationalized by considering an acyclic transition state model. The addition of the allylic reagent occurred to the less hindered Re face of the imine with (RS)-configuration. N-Allylation of compounds 209, followed by ring-closing metathesis with Grubbs second generation catalyst, and removal of the sulfinyl group, led to chiral spirocyclic aminooxindoles 210 in reasonable yields (Scheme 51) [144].


Scheme 51: Stereoselective synthesis of spirocyclic oxindoles 210 from chiral imines (RS)-53.

Azaspirocyclic alkaloids with interesting pharmacological properties have been isolated from skin extracts of dendrotabic frogs, and also from methanol extracts of ants of the species Carabella bicolor. Amongst these alkaloids, (−)-histrionicotoxin displays a potent noncompetitive acetylcholine antagonist activity. It was found that perhydrohistrionicotoxin analogues display similar biological properties. In this regard, Peralta-Hernández and Cordero-Vargas reported the synthesis of an advanced synthetic intermediate 213 of perhydrohistrionicotoxin [145]. The diastereoselective nucleophilic addition of a lithium acetylide to cyclic chiral N-tert-butanesulfinyl imine 211 is a key step in this strategy. The addition proceeded with total stereocontrol to give a single diastereoisomer, and further removal of the silyl group provided propargylamine derivative 212. Partial hydrogenation of this compound under Lindlar conditions led to terminal olefin, which reacted with ethyl iodoacetate in refluxing dichoroethane, in the presence of 1.6 equivalents of lauroyl peroxide (DLP), as thermal initiator of the radical process. A spirolactam was isolated in 45% yield, taking place under the essayed reaction conditions successively a radical addition of the enolate to the terminal alkene, lactonization and removal of the sulfinyl group. Final deprotection of the hydroxy group led to compound 213, a precursor of the 6-(R) epimer of perhydrohistrionicotoxin (Scheme 52).


Scheme 52: Stereoselective synthesis of azaspiro compound 213 from chiral imine 211.

Chiral aromatic sulfinyl imines 214 with a 2-haloethyl substituent at ortho-position were effective synthetic intermediates in the stereoselective preparation of 1-aryl-1,2,3,4-tetrahydroisoquinolines, which are compounds that display interesting biological activities. For instance, solifenacin (216), a competitive muscarinic acetylcholine receptor antagonist currently used in the treatment of overactive bladders, was prepared from (RS)-214a (X = Br) by addition first of phenylmagnesium bromide at –40 °C in toluene. A 93:7 diastereomeric mixture was obtained and the major diastereoisomer was easily isolated after column chromatography. Subsequent intramolecular cyclization in the presence of NaH in DMF at room temperature gave the pure diastereomer 215, a precursor of solefinacin (216) [146]. Diastereoselective allylation of chlorinated derivative (RS)-214b (X = Cl) with allylmagnesium bromide in dichloromethane gave the corresponding homoallylic sulfinamide as a 9:1 mixture of easily separable diastereoisomers, and the major component of the mixture was further cyclized to give product 217, which was transformed after 5 steps into almorexant (218), a non-peptide antagonist of the human orexin receptor, which plays a major role in controlling the sleep/wake cycle [147]. The same precursor (RS)-214b (X = Cl) and strategy was followed in the first steps of the synthesis of compound 220, used as neuroprotective agents in the treatment of neurological diseases, such as epilepsy and ischemia. In this case, the addition of 4-chlorophenylmagnesium bromide to (RS)-214b gave the expected product with 93:7 ratio of diastereoisomers. An intramolecular cyclization of the major diastereoisomer afforded 219 in high yield (Scheme 53) [146].


Scheme 53: Stereoselective synthesis of tetrahydroisoquinoline derivatives from chiral imines (RS)-214.

Asymmetric synthesis of pyrrolizidines, indolizidines and quinolizidines

Bicyclic systems containing bridgehead nitrogen, such as 1-azabicyclo[3.3.0]octanes, 1-azabicyclo[4.3.0]nonanes and 1-azabicyclo[4.4.0]decanes are structural motifs frequently encountered in alkaloids, which can come from quite diverse sources, such as bacteria, fungi, plants and animals, among others. Many of these natural products display extremely potent biological activities and their syntheses, along with that of structurally related analogs, remain of great interest for chemists and pharmacologists. Relevant contributions regarding the synthesis of these bicyclic compounds, involving chiral N-tert-butanesulfinyl imines, are compiled in the following paragraphs.

Initial stereocontrol by allylation of sulfinyl imines

The allylation of chiral N-tert-butanesulfinyl imines is of great synthetic interest because in this reaction together with a new functionality (amino derivative group), a carbon–carbon bond is formed. In addition, the double bond of the allylic moiety can participate in a number of further synthetically useful transformations, including the generation of functional groups prone to participate in intramolecular cyclization processes involving the nitrogen atom of the starting imine. Interestingly, the allylation of these imines can be carried out in a stereoselective fashion with different allylating reagents [66,148,149].

Pyrroloisoquinoline alkaloid (−)-crispine A (223) was isolated from Carduus crispus plants which were used in folk medicine for the treatment of different inflammatory diseases, such as bronchitis, stenocardia, gastroenteritis, and rheumatism. In addition, it also shows promising biological activity against human cancer cell lines. The allylation of chiral imine (RS)-214 with allylmagnesium bromide in dichloromethane at −78 °C was the key step in the synthesis reported by Reddy and co-workers of this alkaloid. The allylated product was obtained in 80% yield as 9:1 mixture of diastereoisomers, and the major diastereoisomer was separated from the mixture and cyclized to give tetrahydroisoquinoline 217 (see above, Scheme 53). The formation of the 5-membered ring to produce target (−)-crispine A (223) was accomplished in six additional steps which comprise removal of the sulfinyl group and subsequent N-Boc protection to give 221, hydroboration–oxidation to produce terminal alcohol derivative 222, and formation of the mesylate, removal of the Boc group, and final cyclization (Scheme 54) [150].


Scheme 54: Stereoselective synthesis of (−)-crispine A 223 from chiral imine (RS)-214.

A similar strategy was described by the same authors for the stereoselective synthesis of (−)-harmicine and other tetrahydro-β-carboline alkaloids. The allylation of chiral imine (RS)-225 with allylmagnesium bromide in dichloromethane at −78 °C was the key step for the synthesis reported by Reddy and co-workers that led to compound 226 in 81% yield (dr > 99:1). After a sequence of similar steps of removal of the sulfinyl group, protection of the amine, hydroboration–oxidation and formation of the mesylate, removal of the Boc group, and final cyclization, the (−)-harmicine (228) was obtained in 72% yield in the last step [151] (Scheme 55).


Scheme 55: Synthesis of (−)-harmicine (228) using tert-butanesulfinamide through haloamide cyclization.

Tetraponerines T1–T8 are tricyclic alkaloids with aminal structure, and depending on the size of the A–B–C rings, they are divided in two groups (5−6−5: T1, T2, T5, T6; or 6−6−5: T3, T4, T7, T8). Other differentiating elements are the alkyl chain at C5-position (n-propyl: T1–T4; n-pentyl: T5–T8), and the configuration of this stereocenter [(R): T1, T3, T5, T7; (S): T2, T4, T6, T8] (Scheme 56). The stereocontrolled synthesis of these alkaloids was reported by Bosque et al. Key step transformations in the stereoselective synthesis of each natural tetraponerine are two consecutive indium-mediated aminoallylations of the appropriate stereoisomer of a chiral N-tert-butylsulfinamide. Allylpyrrolidine derivative 238, which is the precursor of 5−6−5 tetraponerines (T1, T2, T5, T6; 185187), was obtained from 4-bromobutanal (231) in the first aminoallylation, and allyl piperidine derivative 126 (see Scheme 32; precursor of 6−6−5 tetraponerines: T3, T4, T7, T8; 231, 233, 235 and 237, respectively) was prepared from 5-bromopentanal. Importantly, to prepare tetraponerines T5–T8, with a pentyl group at C5-position, a cross-metathesis reaction involving the allyl group of the second aminoallylation with cis-3-hexene was carried out in order to elongate the side chain [152,153]. The anticancer activity of tetraponerines T5–T8 against four different carcinoma human cell lines was also investigated, observing a promising cytotoxic activity of tetraponerine T7 (236) against breast carcinoma cell line MCF-7 [152].


Scheme 56: Stereoselective synthesis of tetraponerines T1–T8.

Taking advantage of this highly diastereoselective indium-mediated amino allylation of carbonyl compounds, an efficient stereocontrolled synthesis of phenanthroindolizidines 246 and phenanthroquinolizidine 7-methoxycryptopleurine 248 was accomplished by Antón-Torrecillas et al., using 2-(phenanthren-9-yl)acetaldehydes 243 as starting materials. The initially formed homoallylamine derivatives 244 were transformed first into pyrrolidines 245 (hydrobroration–oxydation–intramolecular Mitsunobu N-alkylation), and after removal of the sulfinyl group, and a Pictet–Spengler reaction involving formaldehyde, the expected phenanthroindolizidine 246a and the alkaloid (−)-tylophorine (246b) were obtained (Scheme 57) [154]. On the other hand, key chiral homoallyllic sulfinamine intermediate 244b was also transformed in four steps into enantioenriched 7-methoxycryptopleurine 248, a rhodium-catalyzed linear hydroformylation being one of the steps involved in the formation of piperidine derivative 247. Cytotoxic evaluation of both enantiomers of 7-methoxycryptopleurine demonstrated that the compound with (R)-configuration shown in Scheme 57 was much more potent than its antipode against four cancer cell lines examined [155]. Phenanthroquinolizidines with a quaternary center at C-14a position, bearing a methyl group instead of the proton, were prepared following the same methodology, and using the corresponding methyl ketone as starting material. These compounds displayed also cytotoxic activity against different human cancer cell lines [156].


Scheme 57: Stereoselective synthesis of phenanthroindolizidines 246a and (−)-tylophorine (246b), and phenanthroquinolizidine 248.

Indium-mediated allylation of sulfinyl imines was also the source of the stereocontrol in the synthesis of benzo-fused 1-azabicyclo[j.k.0]alkanes 253 and 255 reported by Sirvent et al.. The starting chiral imines (SS)-250 derived from aliphatic aldehydes, with a 2-bromophenyl substituent, and (S)-tert-butanesulfinamide. When the allylation was carried out with ethyl 2-(bromomethyl)acrylate (249), and after removal of the sulfinyl unit, the resulting free amine derivative led to α-methylene-γ-butyrolactams 252. On the other hand, dihydropyridin-2-ones 254 were obtained after sequential allylation with allyl bromide 251, desulfinylation, acylation with acryloyl chloride, and ring-closing metathesis. Lactams 252 and 254 were easily transformed into target polycyclic compounds 253 and 255 by performing an intramolecular N-arylation using Ullmann-type reaction conditions (Scheme 58) [157].


Scheme 58: Stereoselective synthesis of indoline, tetrahydroquinoline and tetrahydrobenzazepine derivatives 253 and 255 from chiral aldimines (SS)-250.

The group of Wei reported a diastereoselective approach for the synthesis of trans-4-hydroxy-5-allyl-2-pyrrolidinone 80 through an indium-mediated allylation of α-chiral aldimine (RS)-79 (see above Scheme 24) [100]. Allyl pyrrolidone 80 was an intermediate in the synthesis of alkaloids (+)-epohelmins A (258) and B (260). These natural products were isolated from an unidentified fungus, and inhibited recombinant lanosterol synthase with low IC50 values, with potential use as anticholesteraemic drugs to complement or even substitute the now widely used members of the statin family. The second five-membered ring of the pyrrolizidinic system in (+)-epohelmin A (258) was constructed from alcohol 257, upon forming the corresponding mesylate, subsequent removal of the Boc group, promoting cyclization, and final desilylation. Compound 256 was the last common intermediate in the diastereodivergent approach to both epohelmins, the corresponding epimer 259 was the precursor of (+)-epohelmin B (260) by applying the same reaction conditions as for (+)-epohelmin A (258, Scheme 59) [158].


Scheme 59: Stereoselective synthesis of (+)-epohelmin A (258) and (+)-epohelmin B (260) from aldimine (RS)-79.

The addition of a lithium anion of N-(diphenylmethylidene)allylimine (262) to chiral sulfinyl imines was investigated by Prasad and co-workers. They found that the reaction with imines derived from aliphatic aldehydes afforded 1,2-diamine derivatives with excellent diastereoselectivity (>99:1). Allylation of chiral imine (SS)-261 with concomitant cyclization led to piperidine 263 as a single diastereoisomer. Removal of diphenylmethylidene group and acylation of the resulting free amine provided compound 264, which after desulfinylation, N-allylation, ring-closing metathesis and catalytic hydrogenation produced the quinolizidine alkaloid (−)-epiquinamide (266), isolated from the skin of the Ecuadoran frog Epipedobates tricolor (Scheme 60) [159].


Scheme 60: Stereoselective synthesis of (−)-epiquinamide (266) from chiral aldimine (SS)-261.

Fustero and co-workers described for the first time the use of N-tert-butanesulfinamide in a desymmetrization-type process involving an intramolecular aza-Michael reaction for obtaining the advanced intermediates 271a and 271b in the total synthesis of (−)-hippodamine (273) and (+)-epi-hippodamine (272). The condensation reaction between the symmetric ketone 267 and (R)-N-tert-butanesulfinamide in the presence of titanium(IV) ethoxide followed by the reductive amination with NaBH4 and double-direction cross-metathesis reaction led to 268a in 50% yield and 268b in 49% yield. These compounds were submitted to the desymmetrization process by an intramolecular aza-Michael reaction using NaH in THF. The applied conditions yielded a mixture of cis-269 and trans-269 diastereoisomers as major product (cis/trans 3:1) and a small amount of other possible isomer 270 was detected (269a/270a 95:5) and (269b/270b 96:4). The addition of nitrogen nucleophile occurred to the Si face of the conjugated ester, opposite to the bulky tert-butyl group gave cis-269a,b as major isomer (Scheme 61). The sulfoxide auxiliary was removed under acid conditions, and after a basification process with saturated aqueous NaHCO3, a second intramolecular aza-Michael reaction took place to the products 271a and 271b with excellent yields and high diastereoselectivity. Since 271a,b is C2-symmetric, the cyclization of cis-269a,b or trans 269a,b as soon as 270a,b gave the same isomer 271. Consequently, 271a was obtained in 90% ee and 271b in >99% ee, as determined by chiral HPLC analysis. After three steps, a mixture of (−)-hippodamine (273) and (+)-epi-hippodamine (272) were obtained in high yield which was separated by column chromatography [160] (Scheme 61).


Scheme 61: Synthesis synthesis of (–)-hippodamine (273) and (+)-epi-hippodamine (272) using chiral sulfinyl amines.

Stereocontrol synthesis through addition of Grignard reagents to N-sulfinyl imines

The group of Lindsley developed new methodologies for the enantioselective synthesis of different azabicyclic systems. These methodologies are based on the diastereoselective addition of Grignard reagents to chiral sulfinyl imines, and applied to the syntheses of the indolizidine alkaloid (+)-grandisine D (279) [161], and pyrrolizidine alkaloid (+)-amabiline (283) [162], starting from imine 274. The addition of a masked acetal organomagnesium compound to sulfinyl imine 274 provided compound 275 in high yield and diastereoselectivity, which after reaction with the appropriate alkylating reagent led to 276 and 280. These compounds were prone to undergo ring-closing metathesis, generating 6- and 5-membered ring systems, respectively. After several steps, acetal derivatives 278 and 282 were transformed into (+)-grandisine D (279) and (+)-amabiline (283). Treatment under acidic conditions of 278 and 282 produced removal of the sulfinyl group and hydrolysis of the acetal, revealing the masked aldehyde. In the final step, an intramolecular hydroamination allowed the formation of the five-membered ring, to complete the construction of the azabicyclic arrays (Scheme 62). The indolozidine alkaloids grandisines were isolated from leaves of the Australian rain forest tree Elaeocarpus grandis, and these alkaloids display selective human δ-opioid receptor affinity. Meanwhile, hepatotoxic (+)-amabiline (283) was found in the seeds and flowers of Borago officinalis.


Scheme 62: Stereoselective synthesis of (+)-grandisine D (279) and (+)-amabiline (283).

The addition of alkynyl or alkenyl Grignard reagents to chiral sulfinyl imine (SS)-126 led to 6-substituted trans-5-hydroxy-2-piperidinones with high diastereoselectivity, which is controlled mainly for the configuration of the stereocenter bearing the silyloxy group with alkenyl reagents, and by the coordination of the silyloxy substitution and stereochemistry of the sulfinamide with alkynyl organomagnesium compounds. The addition of vinylmagnesium bromide to (SS)-126 led, after N-Boc protection to 2-piperidinone 284, a precursor of diolefin 285, which through ring closing metathesis allowed the synthesis of quinolizidinone 286, from which (−)-epiquinamide (266) was prepared after three steps. On the other hand, the reaction of imine (SS)-126 with ethynylmagnesium bromide provided compound 288, which was transformed into the N-allyl-substituted piperidinone 289. Again, a ring-closing metathesis allowed the formation of the bicyclic indolizidinone system 290, an advanced synthetic intermediate of alkaloid (+)-swainsonine (291, Scheme 63) [163]. This alkaloid was found in the fungus Rhizoctonia leguminicola and in plants such as the Australian Swainsona canescens and the North American locoweed Astragalus lentiginosus. It displays a wide range of biological activities, including alteri neoplastic growth and metastasis.


Scheme 63: Stereoselective synthesis of (−)-epiquinamide (266) and (+)-swaisonine (291) from aldimine (SS)-126.

Stereocontrol synthesis through Mannich, nitro-Mannich and Mukaiyama–Mannich reactions of N-sulfinyl imines

Heterocyclic compounds can be obtained through strategies using Mannich reactions [164-166]. It was previously commented that the addition of ethyl 4-nitrobutanoante (203) to chiral sulfinyl imines under basic solvent-free conditions proceeded with high facial diastereoselectivity (Scheme 64 [143]). When the reaction was performed with the imine of 5-bromopentanal, (RS)-76, the nitro-Mannich adduct 292 was formed in 86% yield as a 1:1 mixture of diastereoisomers, considering the stereocenter bearing the nitro group. Taking advantage of this methodology, Benlahrech et al. reported the synthesis of (+)-C(9a)-epi-epiquinamide (294) [167]. Desulfinylation of compound 292 led to quinolizidine derivative 293, taking place two consecutive cyclizations involving the resulting free amino group, the ester and the alkyl bromide functionalities. Although compound 292 was isolated in a 1:1 dr, quinolizidine 293 was formed as a 6:1 mixture of diastereoisomers, due to a rapid epimerization under basic conditions, leading to the thermodynamic most stable isomer. Sequential reductions of the nitro group, the lactam and final N-acetylation of the primary amine were the last steps of this synthesis (Scheme 64).


Scheme 64: Stereoselective synthesis of (+)-C(9a)-epi-epiquinamide (294).

The Lewis acid-promoted addition of silyl enol ethers to chiral sulfinyl imines afforded β-amino ketones in high yields and diastereoselectivities (see above Scheme 24 [100]). Similar levels of stereoselectivity were found performing this type of Mukaiyama–Mannich reactions with enol ethers derived from methyl-conjugated enones. The reaction of chiral imine (SS)-109 with silyl enol ether 295 led to β-amino enone 296. Removal of the sulfinyl group under acidic conditions and subsequent basic treatment with DBU led, after N-alkylation and intramolecular conjugate addition, to cis-quinolizidinone 297 in 41% yield (35% of the trans-isomer). Reduction of the ketone functionality with LAH gave 2-epi-lasubine II, and Mitsunobu inversion of the configuration provide (+)-lasubine II (298) in 81% yield (Scheme 65) [168].


Scheme 65: Stereoselective synthesis of (+)-lasubine II (298) from chiral aldimine (SS)-109.

A straightforward synthesis of the alkaloids (−)-epimyrtine (300a) and (−)-lasubine II (ent-302) from β-amino ketone derivatives 204 was reported by Lahosa et al. These compounds participate in a ʟ-proline organocatalyzed intramolecular Mannich reaction with a second aldehyde (R2CHO) to give cis-2,6-disubstituted piperidin-4-ones 205 (see above Scheme 49 [141]). However, when one of the aldehydes involved in the formation of β-amino ketone 204 (R1CHO) or in the intramolecular Mannich reaction (R2CHO) which is 5-chloro- or 5-bromopentanal, quinolizidinone derivatives 299 or 300 are formed. In both cases, after formation of the piperidine ring through the expected Mannich condensation, a subsequent intramolecular N-alkylation involving the carbon–halogen bond occurred to produce the quinolizidinic systems. The natural alkaloid (−)-epimyrtine (300a), isolated from bilberry (Vaccinium myrtillus) was prepared following this methodology, along with ent-299b, which was transformed in a single step into (−)-lasubine II (ent-302), by diastereoselective reduction with ʟ-selectride (Scheme 66) [141].


Scheme 66: Stereoselective synthesis of (−)-epimyrtine (300a) and (−)-lasubine II (ent-302) from β-amino ketone derivatives 204.

Andrade [8,169,170] and Zhao reported an elegant and efficient methodology for the rapid assembling of chiral N-tert-butanesulfinyl imine (RS)-303 with methyl 2-ethylacrylate to give tricyclic derivative 305, in high yield and diastereoselectivity. Treatment of (RS)-303 with LiHMDS in THF at –78 °C led to the formation of lithiodienamine intermediate 304, which reacted with methyl 2-ethylacrylate, leading to the Michael addition product, and the resulting enolate participated in an intramolecular Mannich reaction to form a six-membered ring. Final addition of an excess of allyl bromide yielded tetrahydrocarbazole 305 in 90% yield. After convenient functional group transformation, diolefin 306 was submitted to ring-closing metathesis to form tetracycle 307. Further removal of the sulfinyl group and N-alkylation with 2-bromoethanol gave compound 308, which is an ideal substrate for the construction of the five-membered ring leading to spiro compound 309, upon reaction with potassium tert-butoxide (Bosch−Rubiralta spirocyclization). Treatment of 309 with LDA at –78 °C and quenching the resulting metalloenamine with methyl cyanoformate furnished (−)-tabersonine (310), and selective hydrogenation of 310 led to (−)-vincadifformine (311). In addition, double hydrogenation of 309 produced (−)-aspidospermidine (312) in 75% yield. All these alkaloids are members of the Aspidosperma family (Scheme 67) [171,172].


Scheme 67: Stereoselective synthesis of (−)-tabersonine (310), (−)-vincadifformine (311), and (−)-aspidospermidine (312).

Stereocontrol by pinacol-type coupling reactions involving N-sulfinyl imines

The alkaloids (+)-epohelmin A (258) and (+)-epohelmin B (260) were prepared from chiral aldehyde 313 and chiral sulfinyl imine 314, through samarium iodide-induced reductive cross-coupling reaction leading to compound 315 in 76% yield, and total diastereoselectivity. After several steps, enone amino triol derivative 316 was prepared and directly transformed into (+)-epohelmin A (258), by applying the same reaction conditions shown in Scheme 59 [158] for the transformation of pyrrolidine derivative 257 into (+)-epohelmin A (258). The epimer (+)-epohelmin B (260) was also prepared from 258, carrying out an oxidation of the alcohol and a diastereoselective reduction with ʟ-selectride of the resulting cyclic ketone (Scheme 68) [173].


Scheme 68: Stereoselective synthesis of (+)-epohelmin A (258) and (+)-epohelmin B (260) from aldehyde 313 and aldimine 314.

Asymmetric synthesis of lysergic acid

In 2013, Liu and colleagues used N-tert-butanesulfinamide in the total synthesis of (+)-lysergic acid (323). The first step was the aminoallylation of aldehyde 317 with allyl bromide and sulfinamide (RS)-1 by means of indium metal, leading to homoallyl derivative 318. Further steps included an N-alkylation and ring-closing metathesis with Grubbs second generation catalyst to generate tetrahydropyridine 320 in high yields. Removal of the silyl protecting group, followed by oxidation of the resulting terminal alcohol and palladium-catalyzed coupling of the aldehyde with 3-chloro-2-iodoaniline afforded indole derivative 322, which is an advanced precursor of target (+)-lysergic acid (323, Scheme 69) [174].


Scheme 69: Total synthesis of (+)-lysergic acid (323) from N-tert-butanesulfinamide (RS)-1.


Important progress has been made in the development of methodologies that make use of stable N-tert-butanesulfinyl imines as chiral reagents in diverse synthetic transformations, being possible to recover the chiral auxiliary at the end of the reaction. The great value of enantiomerically enriched amines as synthetic intermediates in the route to complex organic molecules, including natural products (mostly, alkaloids), has boosted the development of nucleophilic addition protocols to these Davis–Ellman N-sulfinyl imines, since the pioneering work of Davis`s group and subsequent work of Ellman`s group. Interestingly, the existing working models facilitate the prediction of the major diastereoisomer in most cases, making this technology attractive with the aim of synthetic applications.


We thank the continuous financial support from the Spanish Ministerio de Economía y Competitividad (MINECO; project CTQ2014-53695-P, CTQ2014-51912-REDC, CTQ2016-81797-REDC, CTQ2017-85093-P), Ministerio de Ciencia, Innovación y Universidades (RED2018-102387-T, PID2019-107268GB-100), FEDER, the Generalitat Valenciana (PROMETEOII/2014/017), and the University of Alicante (VIGROB-068). We are also grateful for the financial support from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).


  1. Robak, M. T.; Herbage, M. A.; Ellman, J. A. Chem. Rev. 2010, 110, 3600–3740. doi:10.1021/cr900382t
    Return to citation in text: [1] [2] [3] [4]
  2. Ferreira, F.; Botuha, C.; Chemla, F.; Pérez-Luna, A. Chem. Soc. Rev. 2009, 38, 1162–1186. doi:10.1039/b809772k
    Return to citation in text: [1]
  3. Morton, D.; Stockman, R. A. Tetrahedron 2006, 62, 8869–8905. doi:10.1016/j.tet.2006.06.107
    Return to citation in text: [1]
  4. Wakayama, M.; Ellman, J. A. J. Org. Chem. 2009, 74, 2646–2650. doi:10.1021/jo9001883
    Return to citation in text: [1]
  5. Aggarwal, V. K.; Barbero, N.; McGarrigle, E. M.; Mickle, G.; Navas, R.; Suárez, J. R.; Unthank, M. G.; Yar, M. Tetrahedron Lett. 2009, 50, 3482–3484. doi:10.1016/j.tetlet.2009.03.020
    Return to citation in text: [1]
  6. Xia, M.-M.; Li, F.-X.; Ma, Y.-P.; Song, L.-L.; Hou, Y.-N.; Shi, Z.-F.; Cao, X.-P. Adv. Synth. Catal. 2020, 362, 1112–1124. doi:10.1002/adsc.201901543
    Return to citation in text: [1]
  7. Ye, W.; Zhang, L.; Ni, C.; Rong, J.; Hu, J. Chem. Commun. 2014, 50, 10596–10599. doi:10.1039/c4cc05042h
    Return to citation in text: [1]
  8. Kokkonda, P.; Andrade, R. B. Org. Lett. 2019, 21, 9594–9597. doi:10.1021/acs.orglett.9b03762
    Return to citation in text: [1] [2]
  9. Liu, H.; Zhang, X.; Shan, D.; Pitchakuntla, M.; Ma, Y.; Jia, Y. Org. Lett. 2017, 19, 3323–3326. doi:10.1021/acs.orglett.7b01504
    Return to citation in text: [1]
  10. Kazak, M.; Priede, M.; Shubin, K.; Bartrum, H. E.; Poisson, J.-F.; Suna, E. Org. Lett. 2017, 19, 5356–5359. doi:10.1021/acs.orglett.7b02635
    Return to citation in text: [1]
  11. Shao, L.-P.; Si, C.-M.; Mao, Z.-Y.; Zhou, W.; Molinski, T. F.; Wei, B.-G.; Lin, G.-Q. Org. Chem. Front. 2017, 4, 995–1004. doi:10.1039/c7qo00052a
    Return to citation in text: [1]
  12. Tao, W.; Zhou, W.; Zhou, Z.; Si, C.-M.; Sun, X.; Wei, B.-G. Tetrahedron 2016, 72, 5928–5933. doi:10.1016/j.tet.2016.08.038
    Return to citation in text: [1]
  13. Zhou, W.; Nie, X.-D.; Zhang, Y.; Si, C.-M.; Zhou, Z.; Sun, X.; Wei, B.-G. Org. Biomol. Chem. 2017, 15, 6119–6131. doi:10.1039/c7ob01395g
    Return to citation in text: [1]
  14. Cogan, D. A.; Liu, G.; Kim, K.; Backes, B. J.; Ellman, J. A. J. Am. Chem. Soc. 1998, 120, 8011–8019. doi:10.1021/ja9809206
    Return to citation in text: [1] [2]
  15. Cogan, D. A.; Ellman, J. A. J. Am. Chem. Soc. 1999, 121, 268–269. doi:10.1021/ja983217q
    Return to citation in text: [1] [2] [3]
  16. Liu, G.; Cogan, D. A.; Owens, T. D.; Tang, T. P.; Ellman, J. A. J. Org. Chem. 1999, 64, 1278–1284. doi:10.1021/jo982059i
    Return to citation in text: [1] [2]
  17. Jiang, Z.-Y.; Chan, W. H.; Lee, A. W. M. J. Org. Chem. 2005, 70, 1081–1083. doi:10.1021/jo048597e
    Return to citation in text: [1]
  18. Higashibayashi, S.; Tohmiya, H.; Mori, T.; Hashimoto, K.; Nakata, M. Synlett 2004, 457–460. doi:10.1055/s-2004-815409
    Return to citation in text: [1]
  19. Huang, Z.; Zhang, M.; Wang, Y.; Qin, Y. Synlett 2005, 1334–1336. doi:10.1055/s-2005-865234
    Return to citation in text: [1]
  20. Collados, J. F.; Toledano, E.; Guijarro, D.; Yus, M. J. Org. Chem. 2012, 77, 5744–5750. doi:10.1021/jo300919x
    Return to citation in text: [1]
  21. Tabet, S.; Rodeville, N.; Boiteau, J.-G.; Cardinaud, I. Org. Process Res. Dev. 2016, 20, 1383–1387. doi:10.1021/acs.oprd.6b00188
    Return to citation in text: [1]
  22. Davis, F. A.; Friedman, A. J.; Kluger, E. W. J. Am. Chem. Soc. 1974, 96, 5000–5001. doi:10.1021/ja00822a055
    Return to citation in text: [1]
  23. Davis, F. A.; Reddy, R. T.; Reddy, R. E. J. Org. Chem. 1992, 57, 6387–6389. doi:10.1021/jo00050a007
    Return to citation in text: [1] [2]
  24. Davis, F. A.; Reddy, R. E.; Szewczyk, J. M.; Portonovo, P. S. Tetrahedron Lett. 1993, 34, 6229–6232. doi:10.1016/s0040-4039(00)73717-8
    Return to citation in text: [1]
  25. Davis, F. A.; Zhou, P.; Reddy, G. V. J. Org. Chem. 1994, 59, 3243–3245. doi:10.1021/jo00091a001
    Return to citation in text: [1] [2]
  26. Davis, F. A.; Liu, H.; Zhou, P.; Fang, T.; Reddy, G. V.; Zhang, Y. J. Org. Chem. 1999, 64, 7559–7567. doi:10.1021/jo990907j
    Return to citation in text: [1] [2]
  27. Davis, F. A.; Reddy, R. E.; Portonovo, P. S. Tetrahedron Lett. 1994, 35, 9351–9354. doi:10.1016/s0040-4039(00)78540-6
    Return to citation in text: [1]
  28. Davis, F. A.; Srirajan, V.; Titus, D. D. J. Org. Chem. 1999, 64, 6931–6934. doi:10.1021/jo990947n
    Return to citation in text: [1]
  29. Jiang, J.; Schumacher, K. K.; Joullié, M. M.; Davis, F. A.; Reddy, R. E. Tetrahedron Lett. 1994, 35, 2121–2124. doi:10.1016/s0040-4039(00)76775-x
    Return to citation in text: [1]
  30. Davis, F. A.; McCoull, W.; Titus, D. D. Org. Lett. 1999, 1, 1053–1055. doi:10.1021/ol990855k
    Return to citation in text: [1]
  31. Davis, F. A. J. Org. Chem. 2006, 71, 8993–9003. doi:10.1021/jo061027p
    Return to citation in text: [1]
  32. Cainelli, G.; Panunzio, M.; Giacomini, D. Tetrahedron Lett. 1991, 32, 121–124. doi:10.1016/s0040-4039(00)71234-2
    Return to citation in text: [1]
  33. Davis, F. A.; Zhang, Y.; Rao, A.; Zhang, Z. Tetrahedron 2001, 57, 6345–6352. doi:10.1016/s0040-4020(01)00500-2
    Return to citation in text: [1]
  34. Borg, G.; Cogan, D. A.; Ellman, J. A. Tetrahedron Lett. 1999, 40, 6709–6712. doi:10.1016/s0040-4039(99)01351-9
    Return to citation in text: [1]
  35. Kochi, T.; Ellman, J. A. J. Am. Chem. Soc. 2004, 126, 15652–15653. doi:10.1021/ja044753n
    Return to citation in text: [1]
  36. Colyer, J. T.; Andersen, N. G.; Tedrow, J. S.; Soukup, T. S.; Faul, M. M. J. Org. Chem. 2006, 71, 6859–6862. doi:10.1021/jo0609834
    Return to citation in text: [1] [2]
  37. Gatling, S. C.; Jackson, J. E. J. Am. Chem. Soc. 1999, 121, 8655–8656. doi:10.1021/ja991784n
    Return to citation in text: [1]
  38. Wigfield, D. C.; Gowland, F. W. J. Org. Chem. 1977, 42, 1108–1109. doi:10.1021/jo00426a048
    Return to citation in text: [1]
  39. Sirvent, A.; Foubelo, F. Lett. Org. Chem. 2018, 15, 345–348. doi:10.2174/1570178614666171130162244
    Return to citation in text: [1]
  40. Mejuch, T.; Gilboa, N.; Gayon, E.; Wang, H.; Houk, K. N.; Marek, I. Acc. Chem. Res. 2013, 46, 1659–1669. doi:10.1021/ar4000532
    Return to citation in text: [1]
  41. Zimmerman, H. E.; Traxler, M. D. J. Am. Chem. Soc. 1957, 79, 1920–1923. doi:10.1021/ja01565a041
    Return to citation in text: [1]
  42. Yamamoto, Y.; Asao, N. Chem. Rev. 1993, 93, 2207–2293. doi:10.1021/cr00022a010
    Return to citation in text: [1]
  43. Yamamoto, Y.; Komatsu, T.; Maruyama, K. J. Org. Chem. 1985, 50, 3115–3121. doi:10.1021/jo00217a020
    Return to citation in text: [1]
  44. Plobeck, N.; Powell, D. Tetrahedron: Asymmetry 2002, 13, 303–310. doi:10.1016/s0957-4166(02)00099-x
    Return to citation in text: [1]
  45. Pflum, D. A.; Krishnamurthy, D.; Han, Z.; Wald, S. A.; Senanayake, C. H. Tetrahedron Lett. 2002, 43, 923–926. doi:10.1016/s0040-4039(01)02294-8
    Return to citation in text: [1]
  46. Almansa, R.; Guijarro, D.; Yus, M. Tetrahedron: Asymmetry 2008, 19, 603–606. doi:10.1016/j.tetasy.2008.01.038
    Return to citation in text: [1]
  47. Almansa, R.; Guijarro, D.; Yus, M. Tetrahedron: Asymmetry 2008, 19, 2484–2491. doi:10.1016/j.tetasy.2008.10.012
    Return to citation in text: [1]
  48. Almansa, R.; Guijarro, D.; Yus, M. Tetrahedron Lett. 2009, 50, 4188–4190. doi:10.1016/j.tetlet.2009.05.008
    Return to citation in text: [1]
  49. Almansa, R.; Collados, J. F.; Guijarro, D.; Yus, M. Tetrahedron: Asymmetry 2010, 21, 1421–1431. doi:10.1016/j.tetasy.2010.03.046
    Return to citation in text: [1]
  50. González-Gómez, J. C.; Medjahdi, M.; Foubelo, F.; Yus, M. J. Org. Chem. 2010, 75, 6308–6311. doi:10.1021/jo101379u
    Return to citation in text: [1]
  51. McCoull, W.; Davis, F. A. Synthesis 2000, 1347–1365. doi:10.1055/s-2000-7097
    Return to citation in text: [1]
  52. Bulut, A.; Aslan, A.; Dogan, Ö. J. Org. Chem. 2008, 73, 7373–7375. doi:10.1021/jo8010073
    Return to citation in text: [1]
  53. Chi, Y.; Scroggins, S. T.; Boz, E.; Fréchet, J. M. J. J. Am. Chem. Soc. 2008, 130, 17287–17289. doi:10.1021/ja806584q
    Return to citation in text: [1]
  54. Song, X.; Hua, Y.-Z.; Shi, J.-G.; Sun, P.-P.; Wang, M.-C.; Chang, J. J. Org. Chem. 2014, 79, 6087–6093. doi:10.1021/jo500796w
    Return to citation in text: [1]
  55. Pieczonka, A. M.; Jarzyński, S.; Wujkowska, Z.; Leśniak, S.; Rachwalski, M. Tetrahedron Lett. 2015, 56, 6506–6507. doi:10.1016/j.tetlet.2015.10.027
    Return to citation in text: [1]
  56. Rachwalski, M.; Jarzyński, S.; Jasiński, M.; Leśniak, S. Tetrahedron: Asymmetry 2013, 24, 689–693. doi:10.1016/j.tetasy.2013.04.019
    Return to citation in text: [1]
  57. Tanner, D. Angew. Chem., Int. Ed. Engl. 1994, 33, 599–619. doi:10.1002/anie.199405991
    Return to citation in text: [1]
  58. Sweeney, J. B. Chem. Soc. Rev. 2002, 31, 247–258. doi:10.1039/b006015l
    Return to citation in text: [1]
  59. Degennaro, L.; Trinchera, P.; Luisi, R. Chem. Rev. 2014, 114, 7881–7929. doi:10.1021/cr400553c
    Return to citation in text: [1]
  60. Ohno, H. Chem. Rev. 2014, 114, 7784–7814. doi:10.1021/cr400543u
    Return to citation in text: [1]
  61. Sabir, S.; Kumar, G.; Jat, J. L. Asian J. Org. Chem. 2017, 6, 782–793. doi:10.1002/ajoc.201700056
    Return to citation in text: [1]
  62. Morton, D.; Pearson, D.; Field, R. A.; Stockman, R. A. Synlett 2003, 1985–1988. doi:10.1055/s-2003-42028
    Return to citation in text: [1]
  63. Fernández, I.; Valdivia, V.; Gori, B.; Alcudia, F.; Álvarez, E.; Khiar, N. Org. Lett. 2005, 7, 1307–1310. doi:10.1021/ol050080h
    Return to citation in text: [1]
  64. Li, Y.; Ma, Y.; Lu, Z.; Wang, L.; Ren, X.; Sun, Z. Tetrahedron Lett. 2012, 53, 4711–4714. doi:10.1016/j.tetlet.2012.06.100
    Return to citation in text: [1]
  65. García Ruano, J.; Fernández, I.; Prado Catalina, M. d.; Cruz, A. A. Tetrahedron: Asymmetry 1996, 7, 3407–3414. doi:10.1016/s0957-4166(96)00448-x
    Return to citation in text: [1]
  66. Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2013, 113, 5595–5698. doi:10.1021/cr400008h
    Return to citation in text: [1] [2]
  67. Foubelo, F.; Yus, M. Eur. J. Org. Chem. 2014, 485–491. doi:10.1002/ejoc.201301068
    Return to citation in text: [1]
  68. Liu, W.-J.; Zhao, Y.-H.; Sun, X.-W. Tetrahedron Lett. 2013, 54, 3586–3590. doi:10.1016/j.tetlet.2013.04.046
    Return to citation in text: [1]
  69. Maciá, E.; Foubelo, F.; Yus, M. Heterocycles 2019, 99, 248–266. doi:10.3987/com-18-s(f)18
    Return to citation in text: [1]
  70. Moragas, T.; Churcher, I.; Lewis, W.; Stockman, R. A. Org. Lett. 2014, 16, 6290–6293. doi:10.1021/ol502967x
    Return to citation in text: [1]
  71. Zhang, Y.; Tian, H.; Luo, Z.; Liu, X.; Zhao, Y.; Chen, W.; Zhang, H. Tetrahedron Lett. 2018, 59, 3357–3360. doi:10.1016/j.tetlet.2018.07.056
    Return to citation in text: [1]
  72. Chogii, I.; Das, P.; Delost, M. D.; Crawford, M. N.; Njardarson, J. T. Org. Lett. 2018, 20, 4942–4945. doi:10.1021/acs.orglett.8b02074
    Return to citation in text: [1]
  73. Huang, Z.-A.; Liu, H.; Lu, C.-D.; Xu, Y.-J. Org. Lett. 2015, 17, 4042–4045. doi:10.1021/acs.orglett.5b01954
    Return to citation in text: [1]
  74. Yang, Y.; Huang, Y.; Qing, F.-L. Tetrahedron Lett. 2013, 54, 3826–3830. doi:10.1016/j.tetlet.2013.05.048
    Return to citation in text: [1]
  75. Qin, S.; Yao, L.; Luo, Y.; Liu, T.; Xu, J.; Sun, Y.; Wang, N.; Yan, J.; Tang, B.; Yang, G.; Yang, C. Org. Chem. Front. 2020, 7, 3132–3136. doi:10.1039/d0qo00603c
    Return to citation in text: [1]
  76. Reidl, T. W.; Anderson, L. L. Asian J. Org. Chem. 2019, 8, 931–945. doi:10.1002/ajoc.201900229
    Return to citation in text: [1]
  77. Andresini, M.; Degennaro, L.; Luisi, R. Org. Biomol. Chem. 2020, 18, 5798–5810. doi:10.1039/d0ob01251c
    Return to citation in text: [1]
  78. Arya, N.; Jagdale, A. Y.; Patil, T. A.; Yeramwar, S. S.; Holikatti, S. S.; Dwivedi, J.; Shishoo, C. J.; Jain, K. S. Eur. J. Med. Chem. 2014, 74, 619–656. doi:10.1016/j.ejmech.2014.01.002
    Return to citation in text: [1]
  79. Gandhi, D.; Kalal, P.; Agarwal, S. Chem. Biol. Interface 2017, 7, 79–101.
    Return to citation in text: [1]
  80. Zachariah, S. M.; Ramkumar, M.; George, N.; Ashif, M. S. Int. J. Pharm. Sci. Rev. Res. 2015, 30, 211–218.
    Return to citation in text: [1]
  81. Reddy, L. R.; Waman, Y.; Kallure, P.; Nalivela, K. S.; Begum, Z.; Divya, T.; Kotturi, S. Chem. Commun. 2019, 55, 5068–5070. doi:10.1039/c9cc00863b
    Return to citation in text: [1]
  82. Reddy, L. R.; Waman, Y.; Nayak, K.; Baharooni, K.; Kotturi, S. Org. Lett. 2019, 21, 3481–3484. doi:10.1021/acs.orglett.9b00564
    Return to citation in text: [1]
  83. Lima, L. M.; da Silva, B. N. M.; Barbosa, G.; Barreiro, E. J. Eur. J. Med. Chem. 2020, 208, 112829. doi:10.1016/j.ejmech.2020.112829
    Return to citation in text: [1]
  84. Delgado, O.; Monteagudo, A.; Van Gool, M.; Trabanco, A. A.; Fustero, S. Org. Biomol. Chem. 2012, 10, 6758–6766. doi:10.1039/c2ob25845e
    Return to citation in text: [1]
  85. Edupuganti, R.; Davis, F. A. Org. Biomol. Chem. 2012, 10, 5021–5031. doi:10.1039/c2ob25345c
    Return to citation in text: [1]
  86. Albrecht, B. K.; Gehling, V. S.; Hewitt, M. C.; Vaswani, R. G.; Côté, A.; Leblanc, Y.; Nasveschuk, C. G.; Bellon, S.; Bergeron, L.; Campbell, R.; Cantone, N.; Cooper, M. R.; Cummings, R. T.; Jayaram, H.; Joshi, S.; Mertz, J. A.; Neiss, A.; Normant, E.; O’Meara, M.; Pardo, E.; Poy, F.; Sandy, P.; Supko, J.; Sims, R. J., III; Harmange, J.-C.; Taylor, A. M.; Audia, J. E. J. Med. Chem. 2016, 59, 1330–1339. doi:10.1021/acs.jmedchem.5b01882
    Return to citation in text: [1]
  87. Yang, X.-d.; Dong, C.-m.; Chen, J.; Ding, Y.-h.; Liu, Q.; Ma, X.-y.; Zhang, Q.; Chen, Y. Chem. – Asian J. 2013, 8, 1213–1222. doi:10.1002/asia.201300051
    Return to citation in text: [1]
  88. Su, L.; Xu, M.-H. Synthesis 2016, 48, 2595–2602. doi:10.1055/s-0035-1561426
    Return to citation in text: [1] [2]
  89. Dema, H. K.; Foubelo, F.; Yus, M. Helv. Chim. Acta 2012, 95, 1790–1798. doi:10.1002/hlca.201200303
    Return to citation in text: [1]
  90. Lin, Y.-C.; Ribaucourt, A.; Moazami, Y.; Pierce, J. G. J. Am. Chem. Soc. 2020, 142, 9850–9857. doi:10.1021/jacs.0c04091
    Return to citation in text: [1]
  91. Adrio, J.; Carretero, J. C. Chem. Commun. 2019, 55, 11979–11991. doi:10.1039/c9cc05238k
    Return to citation in text: [1]
  92. Nájera, C.; Sansano, J. M. Pure Appl. Chem. 2019, 91, 575–596. doi:10.1515/pac-2018-0710
    Return to citation in text: [1]
  93. Upadhyay, P.; Srivastava, V. Curr. Organocatal. 2016, 3, 243–269. doi:10.2174/2213337202666150812230640
    Return to citation in text: [1]
  94. Rajput, A. P.; Nagarale, D. V. J. Chem. Pharm. Res. 2016, 8, 557–575.
    Return to citation in text: [1]
  95. Reddy, L. R.; Gupta, A. P.; Villhauer, E.; Liu, Y. J. Org. Chem. 2012, 77, 1095–1100. doi:10.1021/jo2024224
    Return to citation in text: [1]
  96. Fustero, S.; Herrera, L.; Lázaro, R.; Rodríguez, E.; Maestro, M. A.; Mateu, N.; Barrio, P. Chem. – Eur. J. 2013, 19, 11776–11785. doi:10.1002/chem.201301591
    Return to citation in text: [1]
  97. Redford, J. E.; McDonald, R. I.; Rigsby, M. L.; Wiensch, J. D.; Stahl, S. S. Org. Lett. 2012, 14, 1242–1245. doi:10.1021/ol3000519
    Return to citation in text: [1]
  98. Zhou, Q.-R.; Wei, X.-Y.; Li, Y.-Q.; Huang, D.; Wei, B.-G. Tetrahedron 2014, 70, 4799–4808. doi:10.1016/j.tet.2014.05.037
    Return to citation in text: [1]
  99. Si, C.-M.; Mao, Z.-Y.; Liu, Y.-W.; Du, Z.-T.; Wei, B.-G.; Lin, G.-Q. Org. Chem. Front. 2015, 2, 1485–1499. doi:10.1039/c5qo00250h
    Return to citation in text: [1]
  100. Si, C.-M.; Shao, L.-P.; Mao, Z.-Y.; Zhou, W.; Wei, B.-G. Org. Biomol. Chem. 2017, 15, 649–661. doi:10.1039/c6ob02523d
    Return to citation in text: [1] [2] [3]
  101. Chogii, I.; Njardarson, J. T. Angew. Chem., Int. Ed. 2015, 54, 13706–13710. doi:10.1002/anie.201506559
    Return to citation in text: [1]
  102. Xu, C.-P.; Huang, P.-Q.; Py, S. Org. Lett. 2012, 14, 2034–2037. doi:10.1021/ol300550x
    Return to citation in text: [1]
  103. Maciá, E.; Foubelo, F.; Yus, M. Tetrahedron 2016, 72, 6001–6010. doi:10.1016/j.tet.2016.07.020
    Return to citation in text: [1]
  104. Procopiou, G.; Lewis, W.; Harbottle, G.; Stockman, R. A. Org. Lett. 2013, 15, 2030–2033. doi:10.1021/ol400720b
    Return to citation in text: [1]
  105. Mendes, J. A.; Merino, P.; Soler, T.; Salustiano, E. J.; Costa, P. R. R.; Yus, M.; Foubelo, F.; Buarque, C. D. J. Org. Chem. 2019, 84, 2219–2233. doi:10.1021/acs.joc.8b03203
    Return to citation in text: [1]
  106. Li, Y.; Xu, M.-H. Org. Lett. 2012, 14, 2062–2065. doi:10.1021/ol300581n
    Return to citation in text: [1]
  107. Green, B. T.; Lee, S. T.; Panter, K. E.; Brown, D. R. Food Chem. Toxicol. 2012, 50, 2049–2055. doi:10.1016/j.fct.2012.03.049
    Return to citation in text: [1]
  108. Kittakoop, P.; Mahidol, C.; Ruchirawat, S. Curr. Top. Med. Chem. 2014, 14, 239–252. doi:10.2174/1568026613666131216105049
    Return to citation in text: [1]
  109. Zhao, G.; Canterbury, D. P.; Taylor, A. P.; Cheng, X.; Mikochik, P.; Bagley, S. W.; Tong, R. Org. Lett. 2020, 22, 458–463. doi:10.1021/acs.orglett.9b04220
    Return to citation in text: [1] [2]
  110. Bari, A.; Iqbal, A.; Khan, Z. A.; Shahzad, S. A.; Yar, M. Synth. Commun. 2020, 50, 2572–2589. doi:10.1080/00397911.2020.1776878
    Return to citation in text: [1]
  111. Brahmachari, G.; Das, S. Tetrahedron Lett. 2012, 53, 1479–1484. doi:10.1016/j.tetlet.2012.01.042
    Return to citation in text: [1]
  112. Fustero, S.; Jiménez, D.; Moscardó, J.; Catalán, S.; del Pozo, C. Org. Lett. 2007, 9, 5283–5286. doi:10.1021/ol702447y
    Return to citation in text: [1]
  113. Lebold, T. P.; Leduc, A. B.; Kerr, M. A. Org. Lett. 2009, 11, 3770–3772. doi:10.1021/ol901435k
    Return to citation in text: [1]
  114. Dobbs, A. P.; Guesné, S. J. J. Synlett 2005, 2101–2103. doi:10.1055/s-2005-871956
    Return to citation in text: [1]
  115. Sales, M.; Charette, A. B. Org. Lett. 2005, 7, 5773–5776. doi:10.1021/ol052436v
    Return to citation in text: [1]
  116. Merino, P.; Tejero, T.; Greco, G.; Marca, E.; Delso, I.; Gómez-SanJuan, A.; Matute, R. Heterocycles 2012, 84, 75. doi:10.3987/rev-11-sr(p)1
    Return to citation in text: [1]
  117. Buffat, M. G. P. Tetrahedron 2004, 60, 1701–1729. doi:10.1016/j.tet.2003.11.043
    Return to citation in text: [1]
  118. Laschat, S.; Dickner, T. Synthesis 2000, 1781–1813. doi:10.1055/s-2000-8218
    Return to citation in text: [1]
  119. Sirvent, J. A.; Foubelo, F.; Yus, M. Heterocycles 2014, 88, 1163–1174. doi:10.3987/com-13-s(s)75
    Return to citation in text: [1]
  120. Lahosa, A.; Soler, T.; Arrieta, A.; Cossío, F. P.; Foubelo, F.; Yus, M. J. Org. Chem. 2017, 82, 7481–7491. doi:10.1021/acs.joc.7b01178
    Return to citation in text: [1] [2]
  121. Bosque, I.; González-Gómez, J. C.; Foubelo, F.; Yus, M. J. Org. Chem. 2012, 77, 780–784. doi:10.1021/jo202211u
    Return to citation in text: [1]
  122. González-Gómez, J. C.; Foubelo, F.; Yus, M. Synlett 2008, 2777–2780. doi:10.1055/s-0028-1083535
    Return to citation in text: [1]
  123. Reddy, A. A.; Prasad, K. R. J. Org. Chem. 2017, 82, 13488–13499. doi:10.1021/acs.joc.7b02611
    Return to citation in text: [1]
  124. Si, C.-M.; Huang, W.; Du, Z.-T.; Wei, B.-G.; Lin, G.-Q. Org. Lett. 2014, 16, 4328–4331. doi:10.1021/ol5020812
    Return to citation in text: [1]
  125. Han, P.; Si, C.-M.; Mao, Z.-Y.; Li, H.-T.; Wei, B.-G.; Du, Z.-T. Tetrahedron 2016, 72, 862–867. doi:10.1016/j.tet.2015.12.057
    Return to citation in text: [1]
  126. Wang, C.; Liu, Y.-W.; Zhou, Z.; Si, C.-M.; Sun, X.; Wei, B.-G. Tetrahedron 2018, 74, 2158–2165. doi:10.1016/j.tet.2018.03.022
    Return to citation in text: [1]
  127. Si, C.-M.; Mao, Z.-Y.; Zhou, Z.; Du, Z.-T.; Wei, B.-G. Tetrahedron 2015, 71, 9396–9402. doi:10.1016/j.tet.2015.10.059
    Return to citation in text: [1]
  128. Liu, Y.-W.; Mao, Z.-Y.; Ma, R.-J.; Yan, J.-H.; Si, C.-M.; Wei, B.-G. Tetrahedron 2017, 73, 2100–2108. doi:10.1016/j.tet.2017.02.057
    Return to citation in text: [1]
  129. Zhang, Z.; Sun, Z. Synlett 2020, 31, 355–358. doi:10.1055/s-0039-1690771
    Return to citation in text: [1]
  130. Zhou, W.; Zhang, Y.-X.; Nie, X.-D.; Si, C.-M.; Sun, X.; Wei, B.-G. J. Org. Chem. 2018, 83, 9879–9889. doi:10.1021/acs.joc.8b01282
    Return to citation in text: [1]
  131. Kaczorek, D.; Kawęcki, R. Tetrahedron Lett. 2020, 61, 152034. doi:10.1016/j.tetlet.2020.152034
    Return to citation in text: [1]
  132. Reddy, Y. V.; Biradar, D. O.; Reddy, B. J. M.; Rathod, A.; Himabindu, M.; Reddya, B. V. S. Nat. Prod. Commun. 2017, 12, 1599–1603. doi:10.1177/1934578x1701201019
    Return to citation in text: [1]
  133. Frederico, D.; Brocksom, U.; Brocksom, T. J. Quim. Nova 2005, 28, 692–702. doi:10.1590/s0100-40422005000400024
    Return to citation in text: [1]
  134. Pinto, A.; Griera, R.; Molins, E.; Fernández, I.; Bosch, J.; Amat, M. Org. Lett. 2017, 19, 1714–1717. doi:10.1021/acs.orglett.7b00492
    Return to citation in text: [1]
  135. Pinto, A.; Piccichè, M.; Griera, R.; Molins, E.; Bosch, J.; Amat, M. J. Org. Chem. 2018, 83, 8364–8375. doi:10.1021/acs.joc.8b00983
    Return to citation in text: [1]
  136. Medjahdi, M.; González-Gómez, J. C.; Foubelo, F.; Yus, M. Heterocycles 2012, 86, 727–734. doi:10.3987/com-12-s(n)27
    Return to citation in text: [1]
  137. Sirvent, A.; García-Muñoz, M. J.; Yus, M.; Foubelo, F. Eur. J. Org. Chem. 2020, 113–126. doi:10.1002/ejoc.201901590
    Return to citation in text: [1]
  138. García-Muñoz, M. J.; Foubelo, F.; Yus, M. J. Org. Chem. 2016, 81, 10214–10226. doi:10.1021/acs.joc.6b01047
    Return to citation in text: [1]
  139. Penk, D. N.; Robinson, N. A.; Hill, H. M.; Turlington, M. Tetrahedron Lett. 2017, 58, 470–473. doi:10.1016/j.tetlet.2016.12.061
    Return to citation in text: [1]
  140. Chowdhury, S.; Mao, J.; Martynow, J.; Zhao, H.; Duffy, E.; Wu, Y.; Thakur, V.; Sirasani, G.; Tang, Y.; Collin, F.; Sinishtaj, S.; Bhattacharjee, A. Tetrahedron Lett. 2019, 60, 371–374. doi:10.1016/j.tetlet.2018.12.061
    Return to citation in text: [1]
  141. Lahosa, A.; Yus, M.; Foubelo, F. J. Org. Chem. 2019, 84, 7331–7341. doi:10.1021/acs.joc.9b01008
    Return to citation in text: [1] [2] [3]
  142. García-Muñoz, M. J.; Foubelo, F.; Yus, M. Heterocycles 2015, 90, 1419–1432. doi:10.3987/com-14-s(k)103
    Return to citation in text: [1]
  143. Hernández-Ibáñez, S.; Soares do Rego Barros, O.; Lahosa, A.; García-Muñoz, M. J.; Benlahrech, M.; Behloul, C.; Foubelo, F.; Yus, M. Tetrahedron 2020, 76, 130842. doi:10.1016/j.tet.2019.130842
    Return to citation in text: [1] [2]
  144. Chen, D.; Xu, M.-H. Chem. Commun. 2013, 49, 1327–1329. doi:10.1039/c2cc38600c
    Return to citation in text: [1]
  145. Peralta-Hernández, E.; Cordero-Vargas, A. Synthesis 2016, 48, 4237–4245. doi:10.1055/s-0035-1562612
    Return to citation in text: [1]
  146. Babu, R. A.; Reddy, N. S. S.; Reddy, B. J. M.; Reddy, B. V. S. Synthesis 2014, 46, 2794–2798. doi:10.1055/s-0034-1378515
    Return to citation in text: [1] [2]
  147. Reddy, N. S. S.; Reddy, B. V. S. Tetrahedron Lett. 2014, 55, 3157–3159. doi:10.1016/j.tetlet.2014.03.130
    Return to citation in text: [1]
  148. Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2011, 111, 7774–7854. doi:10.1021/cr1004474
    Return to citation in text: [1]
  149. Foubelo, F.; Yus, M. Chim. Oggi 2016, 34 (4), 45–49.
    Return to citation in text: [1]
  150. Reddy, N. S. S.; Reddy, B. J. M.; Reddy, B. V. S. Tetrahedron Lett. 2013, 54, 4228–4231. doi:10.1016/j.tetlet.2013.05.132
    Return to citation in text: [1]
  151. Reddy, N. S. S.; Babu, R. A.; Reddy, B. V. S. Synthesis 2016, 48, 1079–1086. doi:10.1055/s-0035-1561562
    Return to citation in text: [1]
  152. Bosque, I.; Gonzalez-Gomez, J. C.; Loza, M. I.; Brea, J. J. Org. Chem. 2014, 79, 3982–3991. doi:10.1021/jo500446f
    Return to citation in text: [1] [2]
  153. Bosque, I.; González-Gómez, J. C.; Guijarro, A.; Foubelo, F.; Yus, M. J. Org. Chem. 2012, 77, 10340–10346. doi:10.1021/jo302045y
    Return to citation in text: [1]
  154. Anton-Torrecillas, C.; Gonzalez-Gomez, J. C. Org. Biomol. Chem. 2014, 12, 7018–7025. doi:10.1039/c4ob01133c
    Return to citation in text: [1]
  155. Anton-Torrecillas, C.; Bosque, I.; Gonzalez-Gomez, J. C.; Loza, M. I.; Brea, J. J. Org. Chem. 2015, 80, 1284–1290. doi:10.1021/jo502660r
    Return to citation in text: [1]
  156. Anton-Torrecillas, C.; Loza, M. I.; Brea, J.; Gonzalez-Gomez, J. C. Org. Biomol. Chem. 2016, 14, 2264–2271. doi:10.1039/c5ob02624e
    Return to citation in text: [1]
  157. Sirvent, J. A.; Foubelo, F.; Yus, M. J. Org. Chem. 2014, 79, 1356–1367. doi:10.1021/jo402759v
    Return to citation in text: [1]
  158. Liu, Y.-W.; Han, P.; Zhou, W.; Mao, Z.-Y.; Si, C.-M.; Wei, B.-G. Org. Biomol. Chem. 2016, 14, 10714–10722. doi:10.1039/c6ob02212j
    Return to citation in text: [1] [2]
  159. Uphade, M. B.; Reddy, A. A.; Khandare, S. P.; Prasad, K. R. Org. Lett. 2019, 21, 9109–9113. doi:10.1021/acs.orglett.9b03507
    Return to citation in text: [1]
  160. Guerola, M.; Sánchez-Roselló, M.; Mulet, C.; del Pozo, C.; Fustero, S. Org. Lett. 2015, 17, 960–963. doi:10.1021/acs.orglett.5b00054
    Return to citation in text: [1]
  161. Fadeyi, O. O.; Senter, T. J.; Hahn, K. N.; Lindsley, C. W. Chem. – Eur. J. 2012, 18, 5826–5831. doi:10.1002/chem.201200629
    Return to citation in text: [1]
  162. Senter, T. J.; Fadeyi, O. O.; Lindsley, C. W. Org. Lett. 2012, 14, 1869–1871. doi:10.1021/ol300466a
    Return to citation in text: [1]
  163. Si, C.-M.; Mao, Z.-Y.; Dong, H.-Q.; Du, Z.-T.; Wei, B.-G.; Lin, G.-Q. J. Org. Chem. 2015, 80, 5824–5833. doi:10.1021/acs.joc.5b00803
    Return to citation in text: [1]
  164. Zhang, W.; Sha, W.; Zhu, Y.; Han, J.; Soloshonok, V. A.; Pan, Y. Eur. J. Org. Chem. 2017, 1540–1546. doi:10.1002/ejoc.201601645
    Return to citation in text: [1]
  165. Thaisrivongs, D. A.; Miller, S. P.; Molinaro, C.; Chen, Q.; Song, Z. J.; Tan, L.; Chen, L.; Chen, W.; Lekhal, A.; Pulicare, S. K.; Xu, Y. Org. Lett. 2016, 18, 5780–5783. doi:10.1021/acs.orglett.6b01793
    Return to citation in text: [1]
  166. Hugelshofer, C. L.; Palani, V.; Sarpong, R. J. Org. Chem. 2019, 84, 14069–14091. doi:10.1021/acs.joc.9b02223
    Return to citation in text: [1]
  167. Benlahrech, M.; Lahosa, A.; Behloul, C.; Foubelo, F.; Yus, M. Heterocycles 2018, 97, 1191–1202. doi:10.3987/com-18-s(t)66
    Return to citation in text: [1]
  168. Reddy, A. A.; Reddy, P. O.; Prasad, K. R. J. Org. Chem. 2016, 81, 11363–11371. doi:10.1021/acs.joc.6b01541
    Return to citation in text: [1]
  169. Chatare, V. K.; Andrade, R. B. Angew. Chem., Int. Ed. 2017, 56, 5909–5911. doi:10.1002/anie.201702530
    Return to citation in text: [1]
  170. Walia, M.; Teijaro, C. N.; Gardner, A.; Tran, T.; Kang, J.; Zhao, S.; O’Connor, S. E.; Courdavault, V.; Andrade, R. B. J. Nat. Prod. 2020, 83, 2425–2433. doi:10.1021/acs.jnatprod.0c00310
    Return to citation in text: [1]
  171. Zhao, S.; Andrade, R. B. J. Org. Chem. 2017, 82, 521–531. doi:10.1021/acs.joc.6b02551
    Return to citation in text: [1]
  172. Zhao, S.; Andrade, R. B. J. Am. Chem. Soc. 2013, 135, 13334–13337. doi:10.1021/ja408114u
    Return to citation in text: [1]
  173. Si, C.-M.; Liu, Y.-W.; Mao, Z.-Y.; Han, P.; Du, Z.-T.; Wei, B.-G. Tetrahedron 2016, 72, 8091–8098. doi:10.1016/j.tet.2016.10.047
    Return to citation in text: [1]
  174. Liu, Q.; Zhang, Y.-A.; Xu, P.; Jia, Y. J. Org. Chem. 2013, 78, 10885–10893. doi:10.1021/jo4018777
    Return to citation in text: [1]
Other Beilstein-Institut Open Science Activities